A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
| Member | Definition | Class |
|---|
| 1-(3-chlorophenyl)piperazine | A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone. | 1-(3-chlorophenyl)piperazine |
| 1-(3-trifluoromethylphenyl)piperazine | A N-arylpiperazine that is piperazine substituted by a 3-(trifluoromethyl)phenyl group at position 1. A serotonergic agonist used as a recreational drug. | 1-(3-(trifluoromethyl)phenyl)piperazine |
| 1-benzylpiperazine | A tertiary amino compound that is piperazine substituted by a benzyl group at position 1. It is a serotonergic agonist used as a recreational drug. | 1-benzylpiperazine |
| 1-indanol | | indan-1-ol |
| 1,2-benzisothiazoline-3-one | An organic heterobicyclic compound based on a fused 1,2-thiazole and benzene bicyclic ring skeleton, with the S atom positioned adjacent to one of the positions of ring fusion. | benzo[d]isothiazol-3-one |
| 2-chloro-n-(4-chlorobiphenyl-2-yl)nicotinamide | A pyridinecarboxamide obtained by formal condensation of the carboxy group of 2-chloronicotinic acid with the amino group of 4'-chlorobiphenyl-2-amine. A fungicide active against a broad range of fungal pathogens including Botrytis spp., Alternaria spp. and Sclerotinia spp. for use on a wide range of crops including fruit, vegetables and ornamentals. | boscalid |
| 2-ethyl-5-carboxypentyl phthalate | A phthalic acid monoester resulting from the formal condensation of one of the carboxy gruops of phthalic acid with the hydroxy group of 5-(hydroxymethyl)heptanoic acid. It is a urinary metabolite of diethylhexyl phthalate. | mono(5-carboxy-2-ethylpentyl) phthalate |
| 2-methyl-4-chlorophenoxy gamma-butyric acid | A monocarboxylic acid that is butyric acid substituted by a 2-methyl-4-chlorophenoxy group at position 4. | 2-methyl-4-chlorophenoxybutyric acid |
| 2-n-octyl-4-isothiazolin-3-one | A member of the class of 1,2-thiazole that is 1,2-thiazol-3-one substituted on the nitrogen (position 2) by an octyl group. A fungicide and antibacterial agent, it is used for treatment of canker and other fungal and bacterial diseases in fruit trees. It is no longer approved for use within the European Union. | octhilinone |
| 2-naphthalenesulfonic acid | A naphthalenesulfonic acid in which the sulfo group is linked to position 2 of the naphthalene ring. | naphthalene-2-sulfonic acid |
| 2-nitropropane | A secondary nitroalkane that is propane in which a hydrogen at position 2 has been replaced by a nitro group. Mainly used as a solvent (b.p. 120degreeC). | 2-nitropropane |
| 3-iodo-2-propynylbutylcarbamate | A carbamate ester that is carbamic acid in which the nitrogen has been substituted by a butyl group and in which the hydrogen of the carboxy group is replaced by a 1-iodoprop-2-yn-3-yl group. A fungicide, it is used as a preservative and sapstain control chemical in wood products and as a preservative in adhesives, paints, latex paper coating, plastic, water-based inks, metal working fluids, textiles, and numerous consumer products. | 3-iodoprop-2-yn-1-yl butylcarbamate |
| 3-methylquinoline | | 3-methylquinoline |
| 3,4-dichloroaniline | A dichloroaniline having the two chloro-substituents at the 3- and 4-positions. | 3,4-dichloroaniline |
| 4-sulfanilic acid | An aminobenzenesulfonic acid that is aniline sulfonated at the para-position. | 4-aminobenzenesulfonic acid |
| 4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid | An aminopyridine that is pyridin-4-amine substituted by chloro groups at positions 3 and 5, a fluoro group at position 6 and a carboxymethoxy group at position 2. | fluroxypyr |
| 5-chloro-2-methyl-4-isothiazolin-3-one | A 1,2-thiazole that is 4-isothiazolin-3-one bearing a methyl group on the nitrogen atom and a chlorine at C-5. It is a powerful biocide and preservative and is the major active ingredient in the commercial product Kathon(TM). | chloromethylisothiazolinone |
| 5-tolyltriazole | A member of the class of benzotriazoles that is 1H-benzotriazole substituted by a methyl group at position 5. | 5-methyl-1H-benzotriazole |
| acamprosate | An organosulfonic acid that is propane-1-sulfonic acid substituted by an acetylamino group at position 3. | acamprosate |
| acetaminophen | A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group. | paracetamol |
| acetochlor | A monocarboxylic acid amide that is N-phenylacetamide carrying an ethyl and a methyl group at positions 2 and 6 respectively on the benzene ring while one of the methyl hydrogens as well as the hydrogen attached to the nitrogen atom have been replaced by a chloro and an ethoxymethyl group respectively. | acetochlor |
| acetophenone | A methyl ketone that is acetone in which one of the methyl groups has been replaced by a phenyl group. | acetophenone |
| acetosulfame | A sulfamate ester that is 1,2,3-oxathiazin-4(3H)-one 2,2-dioxide substituted by a methyl group at position 6. | acesulfame |
| alachlor | An aromatic amide that is N-(2,6-diethylphenyl)acetamide substituted by a methoxymethyl group at at the nitrogen atom while one of the hydrogens of the methyl group has been replaced by a chlorine atom. | alachlor |
| albuterol | A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). | albuterol |
| alprazolam | A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug. | alprazolam |
| aminopyrine | A pyrazolone that is 1,2-dihydro-3H-pyrazol-3-one substituted by a dimethylamino group at position 4, methyl groups at positions 1 and 5 and a phenyl group at position 2. It exhibits analgesic, anti-inflammatory, and antipyretic properties. | aminophenazone |
| amitraz | A tertiary amino compound that is 1,3,5-triazapenta-1,4-diene substituted by a methyl group at position 3 and 2,4-dimethylphenyl groups at positions 1 and 5. | amitraz |
| amitriptyline | An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5. | amitriptyline |
| antazoline | A member of the class of imidazolines that is 2-aminomethyl-2-imidazoline in which the exocyclic amino hydrogens are replaced by benzyl and phenyl groups. Antazoline is only found in individuals that have taken the drug. | antazoline |
| antipyrine | A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2. | antipyrine |
| aromasil | A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer. | exemestane |
| arsenocholine | An arsonium ion that is choline in which the central nitrogen has been replaced by arsenic. | arsenocholine |
| aspartame | A dipeptide obtained by formal condensation of the alpha-carboxy group of L-aspartic acid with the amino group of methyl L-phenylalaninate. Commonly used as an artificial sweetener. | aspartame zwitterion; aspartame |
| asulam | A carbamate ester that is methyl carbamate substituted by a (4-aminophenyl)sulfonyl group at the nitrogen atom. A dihydropteroate synthase inhibitor, it is used (normally as the corresponding sodium salt, asulam-sodium) as a herbicide, mainly for killing bracken. | asulam |
| atenolol | An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent. | atenolol |
| atomoxetine | A secondary amino compound having methyl and 3-(2-methylphenoxy)-3-phenylpropan-1-yl substituents. | atomoxetine |
| atorvastatin | A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases. | atorvastatin |
| atrazine | A diamino-1,3,5-triazine that is 1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6 while one of hydrogens of each amino group is replaced respectively by an ethyl and a propan-2-yl group. | atrazine |
| avapro | A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. | irbesartan |
| azoxystrobin | An aryloxypyrimidine having a 4,6-diphenoxypyrimidine skeleton in which one of the phenyl rings is cyano-substituted at C-2 and the other carries a 2-methoxy-1-(methoxycarbonyl)vinyl substituent, also at C-2. An inhibitor of mitochondrial respiration by blocking electron transfer between cytochromes b and c1, it is used widely as a fungicide in agriculture. | azoxystrobin |
| barbituric acid | A barbiturate, the structure of which is that of perhydropyrimidine substituted at C-2, -4 and -6 by oxo groups. Barbituric acid is the parent compound of barbiturate drugs, although it is not itself pharmacologically active. | barbituric acid |
| bentazone | A benzothiadiazine that is 1H-2,1,3-benzothiadiazin-4(3H)-one 2,2-dioxide substituted by an isopropyl group at position 3. | bentazone |
| benzothiazole | An organic heterobicyclic compound that is a fusion product between benzene and thiazole. The parent of the class of benzothiazoles. | benzothiazole |
| benzotriazole | The simplest member of the class of benzotriazoles that consists of a benzene nucleus fused to a 1H-1,2,3-triazole ring. | benzotriazole |
| bezafibrate | A monocarboxylic acid amide obtained by the formal condensation of the carboxy group of 4-chlorobenzoic acid with the amino group of 2-[4-(2-aminoethyl)phenoxy]-2-methylpropanoic acid. Benafibrate is used for the treatment of hyperlipidaemia. | bezafibrate |
| bisphenol a | A bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups. | bisphenol A |
| bromoxynil | A dibromobenzene that is 2,6-dibromophenol substituted by a cyano group at position 4. | 3,5-dibromo-4-hydroxybenzonitrile |
| bupropion | An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring. | bupropion |
| butachlor | An aromatic amide that is 2-choro-N-(2,6-diethylphenyl)acetamide in which the amide nitrogen has been replaced by a butoxymethyl group. | butachlor |
| caffeine | A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee. | caffeine |
| candesartan | A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. | candesartan |
| carbamazepine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant. | carbamazepine |
| carpropamid | A cyclopropylcarboxamide obtained by formal condensation of the carboxy group of 2,2-dichloro-1-ethyl-3-methylcyclopropanecarboxylic acid with the amino group of 1-(4-chlorophenyl)ethylamine. A rice fungicide with specific action against Pyricularia oryzae. It is not highly toxic to mammals but shows a moderate level of toxicity to birds, fish and earthworms. | carpropamid |
| cetirizine | A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively. | cetirizine |
| chloral hydrate | An organochlorine compound that is the hydrate of trichloroacetaldehyde. | chloral hydrate |
| chlorpyrifos | An organic thiophosphate that is O,O-diethyl hydrogen phosphorothioate in which the hydrogen of the hydroxy group has been replaced by a 3,5,6-trichloropyridin-2-yl group. | chlorpyrifos |
| chlorpyrifos-methyl | An organic thiophosphate that is O,O-dimethyl hydrogen phosphorothioate in which the hydrogen of the hydroxy group has been replaced by a 3,5,6-trichloropyridin-2-yl group. | chlorpyrifos-methyl |
| chlortoluron | A member of the class of phenylureas that is urea in which one of the nitrogens is substituted by two methyl groups while the other is substituted by a 3-chloro-4-methylphenyl group. A herbicide that is non-toxic to honeybees but moderately toxic to mammals, birds, earthworms and most aquatic organisms. | chlorotoluron |
| cilastatin | The thioether resulting from the formal oxidative coupling of the thiol group of L-cysteine with the 7-position of (2Z)-2-({[(1S)-2,2-dimethylcyclopropyl]carbonyl}amino)hept-2-enoic acid. It is an inhibitor of dehydropeptidase I (membrane dipeptidase, 3.4.13.19), an enzyme found in the brush border of renal tubes and responsible for degrading the antibiotic imipenem. Cilastatin is therefore administered (as the sodium salt) with imipenem to prolong the antibacterial effect of the latter by preventing its renal metabolism to inactive and potentially nephrotoxic products. Cilastatin also acts as a leukotriene D4 dipeptidase inhibitor, preventing the metabolism of leukotriene D4 to leukotriene E4. | cilastatin |
| ciprofloxacin | A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively. | ciprofloxacin zwitterion; ciprofloxacin |
| clarithromycin | The 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis. | clarithromycin |
| clomazone | An isoxazolidinone that is 1,2-oxazolidin-3-one substituted by a 2-chlorobenzyl group at position 2 and two methyl groups at position 4. | clomazone |
| clothianidin | An N-nitro compound consisting of 2-nitroguanidine having a (2-chloro-1,3-thiazol-5-yl)methyl group at position 1 and a methyl group at position 3. | (E)-clothianidin; clothianidin |
| clothianidin | An N-nitro compound consisting of 2-nitroguanidine having a (2-chloro-1,3-thiazol-5-yl)methyl group at position 1 and a methyl group at position 3. | (E)-clothianidin; clothianidin |
| clotrimazole | A member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group. | clotrimazole |
| clozapine | A benzodiazepine that is 5H-dibenzo[b,e][1,4]diazepine substituted by a chloro group at position 8 and a 4-methylpiperazin-1-yl group at position 11. It is a second generation antipsychotic used in the treatment of psychiatric disorders like schizophrenia. | clozapine |
| cocaine | A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca. | cocaine |
| codeine | A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. | codeine |
| cyanazine | A chloro-1,3,5-triazine that is 2-chloro-1,3,5-triazine substituted by an ethyl amino and a (2-cyanopropan-2-yl)amino group at positions 6 and 4 respectively. | cyanazine |
| cyanoginosin lr | A microcystin consisting of D-alanyl, L-leucyl, (3S)-3-methyl-D-beta-aspartyl,L-arginyl, 2S,3S,4E,6E,8S,9S)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl, D-gamma-glutamyl, and 2,3-didehydro-N-methylalanyl residues joined into a 25-membered macrocycle. Produced by the cyanobacterium Microcystis aeruginosa, it is the most studied of the microcystins. | microcystin-LR |
| cyanuric acid | The keto tautomer of cyanuric acid. | cyanuric acid; isocyanuric acid |
| cyanuric acid | The enol tautomer of isocyanuric acid. | cyanuric acid; isocyanuric acid |
| cyprodinil | A member of the class of aminopyrimidine that is N-phenylpyrimidin-2-amine carrying additional cyclopropyl and methyl substituents at positions 4 and 6 respectively. A broad spectrum fungicide used to control a range of pathogens including Tapesia yallundae, Botrytis spp., Alternaria spp. and Rhynchospium secalis. Whilst it is a recognised irritant no serious human health concerns have been identified. It is moderately toxic to birds as well as most aquatic organisms and earthworms, but it is not considered toxic to honeybees. | cyprodinil |
| dan 2163 | A member of the class of benzamides resulting from the formal condensation of the carboxy group of 4-amino-5-(ethylsulfonyl)-2-methoxybenzoic acid with the primary amino group of 2-(aminomethyl)-1-ethylpyrrolidine. It is a potent, selective dopamine D2 and D3 receptor antagonist. It is an atypical antipsychotic/antischizophrenic agent with limited extrapyrimidal side effects. | amisulpride |
| decarbamylsaxitoxin | A pyrrolopurine that is 2,6-diiminodecahydropyrrolo[1,2-c]purine carrying an additional hydroxymethyl substituent at position 4 as well as two hydroxy substituents at position 10. A toxin that is isolated from marine dinoflagellates and cyanobacteria and is known to cause paralytic shellfish poisoning. | decarbamoylsaxitoxin |
| deet | A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of m-toluic acid with the nitrogen of diethylamine. First developed by the U.S. Army in 1946 for use by military personnel in insect-infested areas, it is the most widely used insect repellent worldwide. | N,N-diethyl-m-toluamide |
| desmedipham | A carbamate ester that is phenylcarbamic acid in which the hydrogen of the hydroxy group has been replaced by a 3-[(ethoxycarbonyl)amino]phenyl group. It is an agrochemical used as a herbicide. | desmedipham |
| dextromethorphan | A 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene in which the sterocenters at positions 4a, 10 and 10a have S-configuration. It is a prodrug of dextrorphan and used as an antitussive drug for suppressing cough. | dextromethorphan |
| diatrizoic acid | A member of the class of benzoic acids that is benzoic acid having iodo substituents at the 2-, 4- and 6-positions and acetamido substituents at the 3- and 5-positions. It is used, mainly as its N-methylglucamine and sodium salts, as an X-ray contrast medium in gastrointestinal studies, angiography, and urography. | amidotrizoic acid |
| diazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. | diazepam |
| diazinon | A member of the class of pyrimidines that is pyrimidine carrying an isopropyl group at position 2, a methyl group at position 6 and a (diethoxyphosphorothioyl)oxy group at position 4. | diazinon |
| dibenzofuran | A mancude organic heterotricyclic parent that consists of a furan ring flanked by two benzene rings ortho-fused across the 2,3- and 4,5-positions. | dibenzofuran |
| dicamba | A methoxybenzoic acid that is O-methylsalicylic acid substituted by chloro groups at positions 3 and 6. | dicamba |
| dichlobanil | A nitrile that is benzonitrile which is substituted by chlorines at positions 2 and 6. A cellulose synthesis inhibitor, it is used as a pre-emergent and early post-emergent herbicide. | 2,6-dichlorobenzonitrile |
| diclofenac | A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. | diclofenac |
| dieldrin | An organochlorine compound resulting from the epoxidation of the double bond of aldrin. It is the active metabolite of the proinsecticde aldrin. | dieldrin |
| difenoconazole | A member of the class of dioxolanes that is 1,3-dioxolane substituted at position 2 by 2-chloro-4-(4-chlorophenoxy)phenyl and 1,2,4-triazol-1-ylmethyl groups. A broad spectrum fungicide with novel broad-range activity used as a spray or seed treatment. It is moderately toxic to humans, mammals, birds and most aquatic organisms. | difenoconazole |
| diflufenican | A pyridinecarboxamide that is pyridine-3-carboxamide substituted by a 2,4-difluorophenyl group at the carbamoyl nitrogen and a 3-(trifluoromethyl)phenoxy group at position 2. | diflufenican |
| diglyme | A polyether that is the dimethyl ether derivative of diethylene glycol. | diglyme |
| dimethoate | A monocarboxylic acid amide that is N-methylacetamide in which one of the hydrogens of the methyl group attached to the carbonyl moiety is replaced by a (dimethoxyphosphorothioyl)sulfanediyl group. | dimethoate |
| dimethomorph | A mixture of (E)- and (Z)-dimethomorph in an unspecified ratio. It is used as a systemic fungicide used on vines, potatoes, and greenhouse crops; only the Z isomer has fungicidal activity. | dimethomorph |
| diuron | A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which both of the hydrogens attached to one nitrogen are substituted by methyl groups, and one of the hydrogens attached to the other nitrogen is substituted by a 3,4-dichlorophenyl group. | diuron |
| dpx e9636 | A N-sulfonylurea that is N-carbamoyl-3-(ethylsulfonyl)pyridine-2-sulfonamide substituted by a 4,6-dimethoxypyrimidin-2-yl group at the amino nitrogen atom. | rimsulfuron |
| dronedarone | A member of the class of 1-benzofurans used for the treatment of cardiac arrhythmias. | dronedarone |
| ephedrine | A phenethylamine alkaloid that is 2-phenylethanamine substituted by a methyl group at the amino nitrogen and a methyl and a hydroxy group at position 2 and 1 respectively. | (-)-ephedrine |
| eprosartan | A member of the class of imidazoles and thiophenes that is an angiotensin II receptor antagonist used for the treatment of high blood pressure. | eprosartan |
| ethambutol | An ethylenediamine derivative that is ethane-1,2-diamine in which one hydrogen attached to each of the nitrogens is sutstituted by a 1-hydroxybutan-2-yl group (S,S-configuration). It is a bacteriostatic antimycobacterial drug, effective against Mycobacterium tuberculosis and some other mycobacteria. It is used (as the dihydrochloride salt) in combination with other antituberculous drugs in the treatment of pulmonary and extrapulmonary tuberculosis; resistant strains of M. tuberculosis are readily produced if ethambutol is used alone. | ethambutol |
| fenofibrate | A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring. | fenofibrate |
| fenoxycarb | A carbamate ester that is the O-ethyl carbamate of 2-(4-phenoxyphenoxy)ethylamine. | fenoxycarb |
| fenuron | A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which one of the nitrogens is substituted by a phenyl group while the other is substituted by two methyl groups. It is a herbicide used for the control of weeds in beetroot as well as various vegetable and ornamental crops. | fenuron |
| flonicamid | A pyridinecarboxamide that is nicotinamide substituted by a trifluoromethyl group at position 4 and a cyanomethyl group at the carbamoyl nitrogen atom. | flonicamid |
| fluazinam | A member of the class of aminopyridines that is 2-amino-5-(trifluoromethyl)pyridine in which one of the amino hydrogens is replaced by a 3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl group. A fungicide used to control grey mould, downy mildew and other fungal pathogens. | fluazinam |
| fluconazole | A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis. | fluconazole |
| fluometuron | A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which one of the nitrogens is substituted by a 3-(trifluoromethyl)phenyl group while the other is substituted by two methyl groups. It is a herbicide used for the control of broadleaf weeds and annual grasses in cotton. | fluometuron |
| fluorouracil | A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth. | 5-fluorouracil |
| flusilazole | An organosilicon compound that is dimethylsilane in which the hydrogens attached to the silicon are replaced by p-fluorophenyl groups and a hydrogen attached to one of the methyl groups is replaced by a 1H-1,2,4-triazol-1-yl group. It is a broad-sepctrum fungicide used to protect a variety of crops. | flusilazole |
| foe 5043 | An aromatic amide that is acetamide in which the amino hydrogens have been replaced by a propan-2-yl and 4-fluorophenyl groups while the methyl hydrogen is replaced by a [5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]oxy group. | flufenacet |
| furosemide | A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure. | furosemide |
| gabapentin | A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome. | gabapentin |
| gemcitabine | A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. | gemcitabine |
| hydrochlorothiazide | A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. | hydrochlorothiazide |
| ibuprofen | A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. | ibuprofen |
| ifosfamide | The simplest member of the class of ifosfamides that is 1,3,2-oxazaphosphinan-2-amine 2-oxide substituted by 2-chloroethyl groups on both the nitrogen atoms respectively. It is a nitrogen mustard alkylating agent used in the treatment of advanced breast cancer. | ifosfamide |
| imidacloprid | An imidazolidine that is N-nitroimidazolidin-2-imine bearing a (6-chloro-3-pyridinyl)methyl substituent at position 1. | (E)-imidacloprid; (Z)-imidacloprid; imidacloprid |
| imidacloprid | An imidazolidine that is N-nitroimidazolidin-2-imine bearing a (6-chloro-3-pyridinyl)methyl substituent at position 1. | (E)-imidacloprid; (Z)-imidacloprid; imidacloprid |
| imidacloprid | An imidazolidine that is N-nitroimidazolidin-2-imine bearing a (6-chloro-3-pyridinyl)methyl substituent at position 1. | (E)-imidacloprid; (Z)-imidacloprid; imidacloprid |
| indomethacin | A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis. | indometacin |
| iobitridol | A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a 3-hydroxy-2-(hydroxymethyl)propanimido at position 5. | iobitridol |
| iohexol | A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position. | iohexol |
| iomeprol | A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position. | iomeprol |
| iopamidol | A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a (2S)-2-hydroxypropanamido group at the 5-position. | iopamidol |
| iopromide | A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration. | iopromide |
| ioxitalamic acid | An organoiodine compound that is 2,4,6-triiodobenzoic acid substituted by an acetylamino group at position 3 and a (2-hydroxyethyl)carbamoyl group at position 5. It is used as a contrast medium. | iooxitalamic acid |
| ioxynil | A nitrile that is benzonitrile substituted by a hydroxy group at position 4 and iodo groups at positions 3 and 5. | ioxynil |
| irgarol 1051 | A diamino-1,3,5-triazine that is 1,3,5-triazine-2,4-diamine carrying a N-tert-butyl, N'-cyclopropyl and a methylsulfanyl group at position 6. | irgarol 1051 |
| isoproturon | A member of the class of phenylureas that is 1,1-dimethylurea substituted by a p-cumenyl group at position 3. A selective, systemic herbicide used to control annual grasses and broadleaf weeds in cereals, its use within the EU has been banned after September 2017 on the grounds of potential groundwater contamination and risks to aquatic life; there have also been concerns about its endocrine-disrupting properties. | isoproturon |
| kathon 930 | A 1,2-thiazole that is 1,2-thiazol-3(2H)-one substituted by chloro groups at positions 4 and 5 and an octyl group at position 2. It is used as a fungicide. | 4,5-dichloro-2-n-octyl-3(2H)-isothiazolone |
| ketamine | A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. | ketamine |
| ketoprofen | An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2. | ketoprofen |
| kresoxim-methyl | A carboxylic ester that is the methyl ester of (2E)-(methoxyimino){2-[(2-methylphenoxy)methyl]phenyl}acetic acid. A fungicide for the control of scab on apples and pears and other fungal diseases on a wide range of crops. | kresoxim-methyl |
| lamotrigine | A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. | lamotrigine |
| lenacil | A cyclopentapyrimidine that is 6,7-dihydro-1H-cyclopenta[d]pyrimidine-2,4(3H,5H)-dione substituted by a cyclohexyl group at position 3. | lenacil |
| lenticin | An amino acid betaine obtaine by exhaustive methylation of the alpha-amino group of L-tryptophan with concomitant deprotonation of the carboxy group. | hypaphorine |
| levetiracetam | A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine. | levetiracetam |
| lidocaine | The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. | lidocaine |
| linuron | A member of the class of phenylureas that is N-methyl urea substituted by a methoxy group at position 1 and a 3,4-dichlorophenyl group at position 3. | linuron |
| mefenamic acid | An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis. | mefenamic acid |
| mephedrone | An aromatic ketone that is propiophenone substituted at C-4 and at C-beta with methyl and methylamino groups respectively. It is a synthetic stimulant and entactogen drug of the amphetamine and cathinone classes. | mephedrone |
| mesotrione | An aromatic ketone that is cyclohexa-1,3-dione in which one of the hydrogens at position 2 is substituted by a 4-(methanesulfonyl)-2-nitrobenzoyl group. | mesotrione |
| metamitron | A member of the class of 1,2,4-triazines that is 1,2,4-triazin-5(4H)-one substituted by an amino group at position 4, a methyl group at position 3 and a phenyl group at position 6. | metamitron |
| metazachlor | An organochlorine compound that is 2-chloroacetamide substituted by a 2,6-dimethylphenyl and a (1H-pyrazol-1-ylmethyl) group at the nitrogen atom. | metazachlor |
| metformin | A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1. | metformin |
| metformin hydrochloride | A hydrochloride resulting from the reaction of metformin with one molar equivalent of hydrogen chloride. | metformin hydrochloride |
| methamphetamine | A member of the class of amphetamines in which the amino group of (S)-amphetamine carries a methyl substituent. | methamphetamine |
| methiocarb | A carbamate ester obtained by the formal condensation of the phenolic group of 3,5-dimethyl-4-(methylsulfanyl)phenol with the carboxy group of methylcarbamic acid. | methiocarb |
| methomyl | A carbamate ester obtained by the formal condensation of methylcarbamic acid with the hydroxy group of 1-(methylsulfanyl)acetaldoxime. | methomyl |
| methoxuron | A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which one of the nitrogens is substituted by a 3-chloro-4-methoxyphenyl group while the other is substituted by two methyl groups. It is a plant growth regulator and a pre- and post-emergence herbicide used for the control of grasses and broad-leaved weeds in carrots and cereals (e.g. wheat, barley and rye). | metoxuron |
| methoxyfenozide | A carbohydrazide that is hydrazine in which the amino hydrogens have been replaced by 3-methoxy-2-methylbenzoyl, 3,5-dimethylbenzoyl, and tert-butyl groups respectively. | methoxyfenozide |
| methylprednisolone | The 6alpha-stereoisomer of 6-methylprednisolone. | 6alpha-methylprednisolone |
| metoclopramide | A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine. | metoclopramide |
| metoprolol | A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1. | metoprolol |
| metribuzin | A member of the class of 1,2,4-triazines that is 1,2,4-triazin-5(4H)-one substituted by an amino group at position 4, tert-butyl group at position 6 and a methylsulfanyl group at position 3. | metribuzin |
| metronidazole | A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. | metronidazole |
| metsulfuron methyl | A N-sulfonylurea in which the sulfonyl group is attached to a 2-(methoxycarbonyl)phenyl group while a (4-methoxy-6-methyl-1,3,5-triazin-2-yl group replaces one of the amino hydrogens of the remaining urea group. | metsulfuron methyl |
| microcystin rr | | microcystin RR |
| microcystin-lf | A microcystin consisting of D-alanyl, L-leucyl, (3S)-3-methyl-D-beta-aspartyl, L-phenylalanyl, (2S,3S,4E,6E,8S,9S)-3-amino-4,5,6,7-tetradehydro-9-methoxy-2,6,8-trimethyl-10-phenyldecanoyl, D-gamma-glutamyl, and 2,3-didehydro-N-methylalanyl residues joined into a 25-membered macrocycle. | microcystin LF |
| moclobemide | A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression. | moclobemide |
| monuron | A member of the class of 3-(3,4-substituted-phenyl)-1,1-dimethylureas that is urea in which one of the nitrogens is substituted by a p-chlorophenyl group while the other is substituted by two methyl groups. | monuron |
| morphine | A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). | morphine |
| mycophenolic acid | A member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. | mycophenolic acid |
| naltrexone | An organic heteropentacyclic compound that is naloxone substituted in which the allyl group attached to the nitrogen is replaced by a cyclopropylmethyl group. A mu-opioid receptor antagonist, it is used to treat alcohol dependence. | naltrexone |
| naproxen | A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes. | naproxen |
| neohesperidin dihydrochalcone | A member of the dihydrochalcones that is 3,2',4',6'-tetrahydroxy-4-methoxydihydrochalcone attached to a neohesperidosyl residue at position 4' via glycosidic linkage. It is found in sweet orange. | neohesperidin dihydrochalcone |
| neotame | A dipeptide composed of N-(3,3-dimethylbutyl)-L-aspartic acid and methyl L-phenylalanate units joined by a peptide linkage. | neotame |
| nicosulfuron | A N-sulfonylurea that is 2-(carbamoylsulfamoyl)-N,N-dimethylpyridine-3-carboxamide substituted by a 4,6-dimethoxypyrimidin-2-yl group at the amino nitrogen. | nicosulfuron |
| nicotine | A 3-(1-methylpyrrolidin-2-yl)pyridine in which the chiral centre has S-configuration. The naturally occurring and most active enantiomer of nicotine, isolated from Nicotiana tabacum. | (S)-nicotine |
| nitroglycerin | A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain. | nitroglycerin |
| norfloxacin | A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase. | norfloxacin |
| octane | A straight chain alkane composed of 8 carbon atoms. | octane |
| oseltamivir | A cyclohexenecarboxylate ester that is the ethyl ester of oseltamivir acid. An antiviral prodrug (it is hydrolysed to the active free carboxylic acid in the liver), it is used to slow the spread of influenza. | oseltamivir |
| oxazepam | A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5. | oxazepam |
| oxybenzone | A hydroxybenzophenone that is benzophenone which is substituted at the 2- and 4-positions of one of the benzene rings by hydroxy and methoxy groups respectively. | oxybenzone |
| pantoprazole | A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2. | pantoprazole |
| pentamidine | A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease. | pentamidine |
| perfluoro-n-heptanoic acid | A fluoroalkanoic acid that is perfluorinated heptanoic acid. | perfluoroheptanoic acid |
| perfluoro-n-nonanoic acid | A fluoroalkanoic acid that is nonanoic acid in which all of the hydrogens in the alkyl chain are replaced by fluorines. | perfluorononanoic acid |
| perfluorobutyric acid | A monocarboxylic acid that is perfluorinated butyric acid. | perfluorobutyric acid |
| perfluorodecanoic acid | A fluoroalkanoic acid that is perfluorinated decanoic acid. | perfluorodecanoic acid |
| perfluorohexanoic acid | A monocarboxylic acid that is perfluorinated hexanoic acid. | perfluorohexanoic acid |
| perfluorooctanoic acid | A fluoroalkanoic acid that is perfluorinated octanoic acid. | perfluorooctanoic acid |
| perfluoropentanoic acid | A monocarboxylic acid that is perfluorinated pentanoic acid. | perfluoropentanoic acid |
| perfluoroundecanoic acid | A fluoroalkanoic acid that is perfluorinated undecanoic acid. | perfluoroundecanoic acid |
| phenmedipham | A carbamate ester that is (3-methylphenyl)carbamic acid in which the hydrogen of the hydroxy group has been replaced by a 3-[(methoxycarbonyl)amino]phenyl group. | phenmedipham |
| phenylhydrazine | A phenylhydrazine that is the monophenyl derivative of hydrazine. | phenylhydrazine |
| pinoxaden | A pyrazolooxadiazepine that is 7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin which is substituted at positions 8 and 9 by 2,6-diethyl-4-methylphenyl and pivaloyloxy groups, respectively. A pro-herbicide (by hydrolysis of the pivalate ester to give the corresponding enol), it is used for control of grass weeds in cereal crops. | pinoxaden |
| pioglitazone | A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity. | pioglitazone |
| pirimicarb | An aminopyrimidine that is N,N,4,5-tetramethylpyrimidin-2-amine substituted by a (dimethylcarbamoyl)oxy group at position 4. | pirimicarb |
| pravastatin | A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin. | pravastatin |
| prednisolone | A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone. | prednisolone |
| primidone | A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures. | primidone |
| prizes | A carboxamidine that is acetamidine in which the amino hydrogens are substituted by a (6-chloropyridin-3-yl)methyl and a methyl group while the hydrogen attached to the imino nitrogen is replaced by a cyano group. | acetamiprid |
| prochloraz | A member of the class of ureas that is 1H-imidazole-1-carboxamide substituted by a propyl and a 2-(2,4,6-trichlorophenoxy)ethyl group at the amino nitrogen atom. A fungicide active against a wide range of diseases affecting field crops, fruit, turf and vegetables. | prochloraz |
| prometone | A methoxy-1,3,5-triazine that is 6-methoxy-1,3,5-triazine-2,4-diamine in which the one of the hydrogens of each amino group is substituted by an isopropyl group. | prometon |
| prometryne | A diamino-1,3,5-triazine that is N,N'-di(propan-2-yl)-1,3,5-triazine-2,4-diamine substituted by a methylsulfanediyl group at position 6. | prometryn |
| propachlor | An anilide that consists of 2-chloroacetanilide bearing an N-isopropyl substituent. | propachlor |
| propamocarb | A carbamate ester that is the propyl ester of 3-(dimethylamino)propylcarbamic acid. It is a systemic fungicide, used (normally as the hydrochloride salt) for the control of soil, root and leaf diseases caused by oomycetes, particularly Phytophthora and Pythium species. | propamocarb |
| propazine | A diamino-1,3,5-triazine that is N,N'-di(propan-2-yl)-1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6. | propazine |
| propiconazole | The cyclic ketal obtained by formal condensation of 1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone with pentane-1,2-diol. A triazole fungicide, it is used commercially as a diastereoisomeric mixture on soft fruit (including apricots, peaches, nectarines, plums and prunes), nuts (including peanuts, pecans and almonds), mushrooms, and grasses grown for seeds. | propiconazole |
| propranolol | A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3. | propranolol |
| propylene | An alkene that is propane with a double bond at position 1. | propene |
| prosulfocarb | A monothiocarbamic ester that is carbamothioic S-acid substituted by two propyl groups at the nitrogen atom and a benzyl group at the the sulfur atom. | prosulfocarb |
| pseudoephedrine | A member of the class of the class of phenylethanolamines that is (1S)-2-(methylamino)-1-phenylethan-1-ol in which the pro-S hydrogen at position 2 is replaced by a methyl group. | pseudoephedrine |
| pymetrozine | A member of the class of 1,2,4-triazines that is 4,5-dihydro-1,2,4-triazin-3(2H)-one substituted by a methyl group at position 6 and a (pyridin-3-ylmethylidene)amino group at position 4. | pymetrozine |
| pyrachlostrobin | A carbamate ester that is the methyl ester of [2-({[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}methyl)phenyl]methoxycarbamic acid. A fungicide used to control major plant pathogens including Septoria tritici, Puccinia spp. and Pyrenophora teres. | pyraclostrobin |
| pyrazon | A pyridazinone that is pyridazin-3(2H)-one substituted by an amino group at position 5, a chloro group at position 4 and a phenyl group at position 2. | chloridazon |
| pyrimethanil | A member of the class of aminopyrimidines that is N-phenylpyrimidin-2-amine carrying two additional methyl substituents at positions 4 and 6. A fungicide used to control grey mould on fruit, vegetables and ornamentals as well as leaf scab on pome fruit. Also commonly employed to control Botrytis cinerea throughout the winemaking process in grapes, must, fermenting must and wine. | pyrimethanil |
| ranitidine | A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease. | ranitidine |
| reserpine | An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. | reserpine |
| ritonavir | An L-valine derivative that is L-valinamide in which alpha-amino group has been acylated by a [(2-isopropyl-1,3-thiazol-4-yl)methyl]methylcarbamoyl group and in which a hydrogen of the carboxamide amino group has been replaced by a (2R,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. A CYP3A inhibitor and antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir. Also used in combination with dasabuvir sodium hydrate, ombitasvir and paritaprevir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. | ritonavir |
| rosuvastatin | A dihydroxy monocarboxylic acid that is (6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl} hept-6-enoic acid carrying two hydroxy substituents at positions 3 and 5 (the 3R,5S-diastereomer). | rosuvastatin |
| roxithromycin | A major geometrical isomer of roxithromycin. | (E)-roxithromycin |
| saccharin | A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent. | saccharin |
| simazine | A diamino-1,3,5-triazine that is N,N'-diethyl-1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6. | simazine |
| sitagliptin | A triazolopyrazine that exhibits hypoglycemic activity. | sitagliptin |
| sotalol | A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias. | sotalol |
| spironolactone | A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7. | spironolactone |
| spiroxamine | The spiroketal resulting from the formal condensation of 4-tert-butylcyclohexanone with 3-[ethyl(propyl)amino]propane-1,2-diol. An inhibitor of ergosterol synthesis, it is a broad spectrum agricultural fungicide used particularly against powdery mildew in the production of cereals, bananas and grapes. | spiroxamine |
| sulcotrione | An aromatic ketone that is cyclohexane-1,3-dione substituted by a 2-chloro-4-(methylsulfonyl)benzoyl group at position 2. | sulcotrione |
| sulfadiazine | A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position. | sulfadiazine |
| sulfadimethoxine | A sulfonamide consisting of pyrimidine having methoxy substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. | sulfadimethoxine |
| sulfamethazine | A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position. | sulfamethazine |
| sulfamethoxazole | An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxazole |
| sulfapyridine | A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. | sulfapyridine |
| sulfathiazole | A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position. | sulfathiazole |
| sulfluramid | A sulfonamide obtained by the formal condensation of perfluorooctane-1-sulfonic acid with ethylamine. | sulfluramid |
| tebufenozide | A carbohydrazide that is hydrazine in which the amino hydrogens have been replaced by tert-butyl, 3,5-dimethylbenzoyl and 4-ethylbenzoyl groups respectively. It is an insecticide used widely against caterpillars. | tebufenozide |
| teflubenzuron | A N-acylurea that is N-carbamoyl-2,6-difluorobenzamide substituted by a 3,5-dichloro-2,4-difluorophenyl group at the terminal nitrogen atom. | teflubenzuron |
| telmisartan | A member of the class of benzimidazoles used widely in the treatment of hypertension. | telmisartan |
| terbutryne | A methylthio-1,3,5-triazine that is 2-(methylsulfanyl)-1,3,5-triazine substituted by a tert-butylamino and an ethylamino group at positions 2 and 4 respectively. | terbutryn |
| terbutylazine | A diamino-1,3,5-triazine that is N-tert-butyl-N'-methyl-1,3,5-triazine-2,4-diamine substituted by a chloro group at position 6. | terbutylazine |
| tetramisole | An imidazothiazole that is imidazo[2,1-b][1,3]thiazole in which the double bonds at the 2-3 and 5-6 positions have been reduced to single bonds and in which one of the hydrogens at position 6 is replaced by a phenyl group. | 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole |
| thiacloprid | A nitrile that is cyanamide in which the hydrogens are replaced by a 1,3-thiazolidin-2-ylidene group which in turn is substituted by a (6-chloropyridin-3-yl)methyl group at the ring nitrogen. | thiacloprid |
| thiamethoxam | An oxadiazane that is tetrahydro-N-nitro-4H-1,3,5-oxadiazin-4-imine bearing (2-chloro-1,3-thiazol-5-yl)methyl and methyl substituents at positions 3 and 5 respectively. | thiamethoxam |
| thifensulfuron methyl | A methyl ester resulting from the formal condensation of the carboxy group of thifensulfuron with methanol. It is used as a post-emergence herbicide for the control of grass and broad-leaved weeds. | thifensulfuron-methyl |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. | thiopental |
| trichlorosucrose | A disaccharide derivative consisting of 4-chloro-4-deoxy-alpha-D-galactopyranose and 1,6-dichloro-1,6-dideoxy-beta-D-fructofuranose units linked by a glycosidic bond. | sucralose |
| triclocarban | A member of the class of phenylureas that is urea substituted by a 4-chlorophenyl group and a 3,4-dichlorophenyl group at positions 1 and 3 respectively. | triclocarban |
| triclopyr | A monocarboxylic acid that is (pyridin-2-yloxy)acetic acid substituted by chloro groups at positions 3, 5 and 6. It is an agrochemical used as a herbicide. | trichlopyr |
| triclosan | An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. | triclosan |
| trifluralin | A substituted aniline that is N,N-dipropylaniline substituted by a nitro groups at positions 2 and 6 and a trifluoromethyl group at position 4. It is an agrochemical used as a pre-emergence herbicide. | trifluralin |
| trimethoprim | An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. | trimethoprim |
| trimipramine | A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)-2-methylpropyl group at the nitrogen atom. It is used as an antidepressant. | trimipramine |
| triphenylmethane | A triarylmethane in which the three aryl groups are phenyl. It forms the basic skeleton of several synthetic dyes. | triphenylmethane |
| troleandomycin | A semi-synthetic macrolide antibiotic obtained by acetylation of the three free hydroxy groups of oleandomycin. Troleandomycin is only found in individuals that have taken the drug. | troleandomycin |
| tylosin | A macrolide antibiotic that is tylonolide having mono- and diglycosyl moieties attached to two of its hydroxy groups. It is found naturally as a fermentation product of Streptomyces fradiae. | tylosin |
| valsartan | A monocarboxylic acid amide consisting of L-valine in which the amino hydrogens have been replaced by a pentanoyl and a [2'-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl group. It exhibits antihypertensive activity. | valsartan |
| venlafaxine | A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group. | venlafaxine |
| yunaconitine | A diterpene alkaloid with formula C35H49NO11 that is isolated from several Aconitum species. | yunaconitine |
| zithromax | A macrolide antibiotic useful for the treatment of bacterial infections. | azithromycin |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 10 kDa chaperonin | Escherichia coli | IC50 | 175.0000 | 4 | 6 |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 137.5000 | 3 | 4 |
| 20-hydroxy-ecdysone receptor | Nezara viridula (southern green stink bug) | IC50 | 24.0000 | 2 | 2 |
| 20-hydroxy-ecdysone receptor | Anthonomus grandis (boll weevil) | Ki | 12.5892 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Chilo suppressalis (striped riceborer) | Ki | 0.0013 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Choristoneura fumiferana (eastern spruce budworm) | Ki | 0.0005 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Leptinotarsa decemlineata (Colorado potato beetle) | Ki | 2.5119 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Locusta migratoria (migratory locust) | Ki | 100.0000 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Nezara viridula (southern green stink bug) | Ki | 22.1781 | 5 | 5 |
| 20-hydroxy-ecdysone receptor | Plodia interpunctella (Indianmeal moth) | Ki | 0.0032 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | IC50 | 0.0520 | 7 | 9 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | Ki | 23.6690 | 3 | 3 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | IC50 | 0.0088 | 7 | 13 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | Ki | 0.0150 | 1 | 1 |
| 3-ketoacyl-CoA synthase 18 | Arabidopsis thaliana (thale cress) | IC50 | 0.1000 | 1 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | IC50 | 12.2000 | 1 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | IC50 | 12.2000 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli | IC50 | 850.0000 | 1 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | Sus scrofa (pig) | IC50 | 1,000.0000 | 1 | 1 |
| 30S ribosomal protein S1 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S10 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S11 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S12 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S13 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S14 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S15 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S16 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S17 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S18 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S19 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S2 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S20 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S21 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S3 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S4 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S5 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S6 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S7 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S8 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 30S ribosomal protein S9 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 1.1000 | 1 | 2 |
| 4-hydroxyphenylpyruvate dioxygenase | Arabidopsis thaliana (thale cress) | IC50 | 0.2500 | 1 | 1 |
| 4-hydroxyphenylpyruvate dioxygenase | Arabidopsis thaliana (thale cress) | Ki | 0.0130 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | IC50 | 2.0655 | 2 | 2 |
| 5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | IC50 | 2.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 2.0976 | 10 | 16 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Ki | 0.1591 | 16 | 19 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 4.2630 | 20 | 28 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 2.8968 | 7 | 10 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | Ki | 0.8728 | 10 | 14 |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | IC50 | 0.6100 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | IC50 | 2.8103 | 3 | 3 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | Ki | 0.0778 | 5 | 5 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | IC50 | 2.8103 | 3 | 3 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | Ki | 0.0778 | 5 | 5 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | IC50 | 2.1163 | 4 | 12 |
| 5-hydroxytryptamine receptor 2A | Mus musculus (house mouse) | IC50 | 0.0280 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 1.9558 | 18 | 19 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.1602 | 42 | 53 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.3785 | 28 | 29 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | IC50 | 1.9980 | 3 | 9 |
| 5-hydroxytryptamine receptor 2B | Mus musculus (house mouse) | IC50 | 0.0280 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 18.3115 | 15 | 15 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 0.6540 | 9 | 13 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.8298 | 13 | 13 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | IC50 | 2.3304 | 5 | 13 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 1.0948 | 13 | 13 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | Ki | 0.3547 | 29 | 38 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 1.2251 | 17 | 17 |
| 5-hydroxytryptamine receptor 2C | Mus musculus (house mouse) | IC50 | 0.0280 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Cavia porcellus (domestic guinea pig) | IC50 | 110.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | IC50 | 0.6013 | 3 | 3 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | Ki | 14.5968 | 6 | 10 |
| 5-hydroxytryptamine receptor 3A | Mus musculus (house mouse) | Ki | 0.1440 | 2 | 3 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | Ki | 0.3733 | 9 | 10 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | IC50 | 0.6013 | 3 | 3 |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | Ki | 16.1980 | 5 | 9 |
| 5-hydroxytryptamine receptor 3B | Mus musculus (house mouse) | Ki | 0.2000 | 1 | 2 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | Ki | 0.3733 | 9 | 10 |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | Ki | 16.1980 | 5 | 9 |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | Ki | 16.1980 | 5 | 9 |
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | Ki | 16.1980 | 5 | 9 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | IC50 | 3.1085 | 2 | 8 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | Ki | 1.6265 | 2 | 8 |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | Ki | 0.2239 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | Ki | 0.1905 | 2 | 2 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Mus musculus (house mouse) | Ki | 8.7000 | 2 | 2 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | Ki | 0.3010 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | Ki | 0.3010 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 2.7587 | 5 | 10 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.5495 | 19 | 27 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | Ki | 0.3010 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 47.9000 | 1 | 12 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | Ki | 0.3113 | 31 | 37 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | Ki | 0.1680 | 4 | 4 |
| 5'-nucleotidase | Homo sapiens (human) | IC50 | 8.2000 | 1 | 1 |
| 5'-nucleotidase | Rattus norvegicus (Norway rat) | IC50 | 70.1000 | 1 | 1 |
| 50S ribosomal protein L1 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L10 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L11 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L13 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L14 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L15 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L16 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L17 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L18 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L19 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L2 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L20 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L21 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L22 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L23 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L24 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L25 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L27 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L28 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L29 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L3 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L30 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L31 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L32 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L33 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L34 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L35 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L36 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L4 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L5 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L6 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | IC50 | 0.3000 | 1 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | Homo sapiens (human) | Ki | 1,119.1500 | 1 | 2 |
| 60 kDa chaperonin | Escherichia coli K-12 | IC50 | 250.0000 | 1 | 2 |
| 60 kDa chaperonin | Escherichia coli | IC50 | 175.0000 | 4 | 6 |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | IC50 | 137.5000 | 3 | 4 |
| Acetylcholine receptor subunit alpha | Homo sapiens (human) | IC50 | 65.4011 | 5 | 7 |
| Acetylcholine receptor subunit alpha | Tetronarce californica (Pacific electric ray) | IC50 | 0.0025 | 2 | 2 |
| Acetylcholine receptor subunit alpha | Homo sapiens (human) | Ki | 3.3139 | 4 | 4 |
| Acetylcholine receptor subunit alpha | Tetronarce californica (Pacific electric ray) | Ki | 8.1350 | 2 | 2 |
| Acetylcholine receptor subunit alpha-like 1 | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Acetylcholine receptor subunit alpha-like 2 | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Acetylcholine receptor subunit beta | Homo sapiens (human) | IC50 | 4.2020 | 4 | 4 |
| Acetylcholine receptor subunit beta | Tetronarce californica (Pacific electric ray) | IC50 | 0.0025 | 2 | 2 |
| Acetylcholine receptor subunit beta | Homo sapiens (human) | Ki | 3.3139 | 4 | 4 |
| Acetylcholine receptor subunit beta | Tetronarce californica (Pacific electric ray) | Ki | 8.1350 | 2 | 2 |
| Acetylcholine receptor subunit beta-like 1 | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Acetylcholine receptor subunit beta-like 2 | Drosophila melanogaster (fruit fly) | IC50 | 0.8024 | 2 | 5 |
| Acetylcholine receptor subunit beta-like 2 | Drosophila melanogaster (fruit fly) | Ki | 0.5427 | 2 | 5 |
| Acetylcholine receptor subunit delta | Homo sapiens (human) | IC50 | 4.2020 | 4 | 4 |
| Acetylcholine receptor subunit delta | Tetronarce californica (Pacific electric ray) | IC50 | 0.0025 | 2 | 2 |
| Acetylcholine receptor subunit delta | Homo sapiens (human) | Ki | 3.3139 | 4 | 4 |
| Acetylcholine receptor subunit delta | Tetronarce californica (Pacific electric ray) | Ki | 8.1350 | 2 | 2 |
| Acetylcholine receptor subunit gamma | Homo sapiens (human) | IC50 | 4.2020 | 4 | 4 |
| Acetylcholine receptor subunit gamma | Tetronarce californica (Pacific electric ray) | IC50 | 0.0025 | 2 | 2 |
| Acetylcholine receptor subunit gamma | Homo sapiens (human) | Ki | 3.3139 | 4 | 4 |
| Acetylcholine receptor subunit gamma | Tetronarce californica (Pacific electric ray) | Ki | 8.1350 | 2 | 2 |
| Acetylcholine-binding protein | Lymnaea stagnalis (great pond snail) | Ki | 0.3799 | 7 | 11 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | IC50 | 10.0000 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 49.8702 | 5 | 6 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | Ki | 109.0000 | 1 | 1 |
| Acetylcholinesterase | Drosophila melanogaster (fruit fly) | IC50 | 1.8300 | 1 | 1 |
| Acid-sensing ion channel 1 | Rattus norvegicus (Norway rat) | IC50 | 288.0192 | 5 | 9 |
| Acid-sensing ion channel 3 | Rattus norvegicus (Norway rat) | IC50 | 512.8610 | 1 | 1 |
| Acrosin | Sus scrofa (pig) | Ki | 2.3000 | 1 | 1 |
| Acyl-CoA desaturase 1 | Mus musculus (house mouse) | IC50 | 0.0080 | 1 | 1 |
| Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | Ki | 0.2990 | 1 | 1 |
| Adenosine receptor A1 | Homo sapiens (human) | IC50 | 13.4200 | 1 | 1 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 487.2000 | 3 | 5 |
| Adenosine receptor A1 | Cavia porcellus (domestic guinea pig) | Ki | 100.0000 | 5 | 6 |
| Adenosine receptor A1 | Homo sapiens (human) | Ki | 33.7081 | 16 | 16 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | Ki | 36.4957 | 31 | 34 |
| Adenosine receptor A2a | Homo sapiens (human) | IC50 | 12.7316 | 2 | 3 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | IC50 | 315.5000 | 2 | 8 |
| Adenosine receptor A2a | Cavia porcellus (domestic guinea pig) | Ki | 50.0000 | 3 | 3 |
| Adenosine receptor A2a | Homo sapiens (human) | Ki | 19.8991 | 21 | 22 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | Ki | 160.9033 | 25 | 30 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | IC50 | 63.0000 | 1 | 5 |
| Adenosine receptor A2b | Homo sapiens (human) | Ki | 26.7211 | 19 | 19 |
| Adenosine receptor A2b | Mus musculus (house mouse) | Ki | 23.0000 | 1 | 1 |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | Ki | 35.3050 | 15 | 20 |
| Adenosine receptor A3 | Homo sapiens (human) | IC50 | 4.1712 | 2 | 4 |
| Adenosine receptor A3 | Homo sapiens (human) | Ki | 28.4198 | 13 | 15 |
| Adenosine receptor A3 | Rattus norvegicus (Norway rat) | Ki | 56.6667 | 6 | 6 |
| Adenylate cyclase type 1 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 2 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 3 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 4 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 6 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylate cyclase type 8 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Adenylyl cyclase 7 | Rattus norvegicus (Norway rat) | IC50 | 0.1400 | 1 | 1 |
| Albumin | Bos taurus (cattle) | IC50 | 3.0000 | 1 | 1 |
| Albumin | Homo sapiens (human) | Ki | 123,119,897,571.4286 | 1 | 7 |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | IC50 | 5.0000 | 1 | 2 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 90.7500 | 2 | 4 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | IC50 | 6.9305 | 1 | 8 |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | Ki | 6.8731 | 1 | 8 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 1.7500 | 1 | 2 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 85.9820 | 4 | 5 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | Ki | 0.8100 | 1 | 1 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 38.7537 | 7 | 8 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | Ki | 0.2200 | 1 | 1 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 5.3431 | 11 | 13 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | Ki | 0.8900 | 3 | 3 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 88.5000 | 3 | 4 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | IC50 | 2.6209 | 2 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 12.0204 | 13 | 16 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Ki | 0.0201 | 6 | 6 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0108 | 12 | 18 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | IC50 | 0.2300 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 12.8218 | 12 | 15 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Ki | 0.0964 | 6 | 7 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 1.0104 | 13 | 18 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | IC50 | 3.8455 | 2 | 4 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 15.0545 | 11 | 12 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Ki | 0.9437 | 6 | 8 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.8887 | 10 | 13 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 2.7952 | 3 | 8 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.1522 | 3 | 4 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Ki | 0.6927 | 5 | 10 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0758 | 6 | 7 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 2.4066 | 2 | 5 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.1522 | 3 | 4 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Ki | 0.9508 | 3 | 6 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0823 | 4 | 5 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 1.2697 | 3 | 4 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 5.1522 | 3 | 4 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Ki | 0.0447 | 4 | 5 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 0.0823 | 4 | 5 |
| Amiloride-sensitive amine oxidase [copper-containing] | Homo sapiens (human) | Ki | 0.2900 | 1 | 1 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | IC50 | 265.8412 | 35 | 37 |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | Ki | 0.3226 | 8 | 10 |
| Amine oxidase [flavin-containing] A | Bos taurus (cattle) | IC50 | 11.7658 | 4 | 4 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | IC50 | 7.7000 | 3 | 3 |
| Amine oxidase [flavin-containing] A | Bos taurus (cattle) | Ki | 26.2500 | 5 | 6 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | Ki | 5.8854 | 2 | 2 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | IC50 | 6,715.0000 | 3 | 3 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | IC50 | 397.3356 | 9 | 10 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | IC50 | 441.6550 | 2 | 2 |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | Ki | 151.6429 | 6 | 7 |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | Ki | 470.0925 | 14 | 16 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | Ki | 68.1426 | 4 | 4 |
| Aminopeptidase N | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 0.3380 | 1 | 1 |
| Androgen receptor | Homo sapiens (human) | IC50 | 4.8946 | 9 | 9 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 24.5685 | 2 | 8 |
| Androgen receptor | Homo sapiens (human) | Ki | 2.0204 | 4 | 4 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 10.5443 | 1 | 5 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 11.4705 | 2 | 4 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 11.9838 | 1 | 3 |
| Angiotensin-converting enzyme | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
| Angiotensin-converting enzyme | Homo sapiens (human) | Ki | 6.0000 | 1 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | Homo sapiens (human) | IC50 | 44.0000 | 1 | 1 |
| Aromatase | Homo sapiens (human) | IC50 | 2.1811 | 11 | 11 |
| Aromatase | Homo sapiens (human) | Ki | 0.0181 | 2 | 2 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 123.9064 | 1 | 55 |
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | IC50 | 57.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 108.7300 | 24 | 43 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 34.7167 | 4 | 12 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 178.4569 | 6 | 13 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | Ki | 410.3413 | 2 | 8 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 21.0000 | 1 | 1 |
| Aurora kinase B | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | IC50 | 2.6315 | 15 | 21 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0120 | 2 | 3 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Ki | 0.8109 | 7 | 13 |
| Beta-1 adrenergic receptor | Mus musculus (house mouse) | Ki | 0.0257 | 1 | 2 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.9102 | 10 | 17 |
| Beta-1 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.0347 | 1 | 1 |
| Beta-1 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1500 | 1 | 1 |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | IC50 | 6.6434 | 3 | 5 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.1019 | 3 | 3 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | IC50 | 2.2073 | 9 | 13 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0440 | 3 | 4 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Ki | 1.8280 | 1 | 1 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Ki | 1.8079 | 8 | 14 |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.4220 | 3 | 5 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | IC50 | 20.4001 | 4 | 7 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0120 | 2 | 3 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Ki | 25.4160 | 1 | 4 |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | Ki | 2.4220 | 3 | 5 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 7.9600 | 2 | 2 |
| Beta-lactamase | Escherichia coli K-12 | IC50 | 191.0000 | 3 | 5 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Cryptosporidium parvum | IC50 | 14.0000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Leishmania major | IC50 | 20.5000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium berghei ANKA | IC50 | 0.1200 | 5 | 5 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | IC50 | 68.2550 | 2 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | IC50 | 80.5069 | 46 | 59 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Leishmania major | Ki | 0.1200 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | Ki | 1.8558 | 7 | 7 |
| Bifunctional epoxide hydrolase 2 | Homo sapiens (human) | IC50 | 0.5065 | 2 | 2 |
| Bile acid receptor | Homo sapiens (human) | IC50 | 3.2400 | 1 | 1 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 294.0158 | 11 | 154 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 610.0500 | 1 | 8 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 1,283.2002 | 9 | 11 |
| C-C chemokine receptor type 4 | Homo sapiens (human) | IC50 | 1.6000 | 1 | 1 |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | IC50 | 6.3313 | 5 | 8 |
| C-X-C chemokine receptor type 3 | Homo sapiens (human) | IC50 | 0.0500 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | Rattus norvegicus (Norway rat) | IC50 | 70.0000 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | Rattus norvegicus (Norway rat) | IC50 | 70.0000 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | Ki | 5.1000 | 1 | 1 |
| Calmodulin-1 | Homo sapiens (human) | IC50 | 80.0000 | 2 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | IC50 | 747.0000 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | Ki | 1.1150 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | Ki | 1.1150 | 1 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | Ki | 1.1150 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 132.2750 | 2 | 52 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | Ki | 295.0000 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | Ki | 172.0000 | 1 | 1 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 11.1573 | 2 | 3 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 12.5000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.1040 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.0634 | 1 | 2 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 0.5725 | 1 | 2 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.0403 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.4416 | 1 | 2 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 3,900.9586 | 5 | 16 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 39.4040 | 44 | 101 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 61.9609 | 13 | 51 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 60.8642 | 4 | 39 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 58.8445 | 5 | 40 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 9.2300 | 1 | 1 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 17,330,479,164.3357 | 8 | 21 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 32.0550 | 52 | 114 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 0.7920 | 1 | 1 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 32.8520 | 1 | 4 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 243.7351 | 5 | 40 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | IC50 | 100.0000 | 2 | 4 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 56.6826 | 7 | 42 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 77.2039 | 6 | 41 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 64.7843 | 6 | 41 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 13.7228 | 1 | 6 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 69.6460 | 7 | 45 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 56.0109 | 7 | 42 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 100.0000 | 2 | 2 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 58.0380 | 17 | 57 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.6145 | 1 | 2 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | Ki | 0.0600 | 1 | 1 |
| Carboxylic ester hydrolase | Musca domestica (house fly) | IC50 | 9.5100 | 1 | 1 |
| Carboxylic ester hydrolase | Plutella xylostella (diamondback moth) | IC50 | 1,355.5000 | 2 | 2 |
| Carnitine O-palmitoyltransferase 1, liver isoform | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Caspase-1 | Homo sapiens (human) | IC50 | 27.0533 | 1 | 15 |
| Caspase-3 | Homo sapiens (human) | IC50 | 33.2933 | 4 | 18 |
| Caspase-4 | Homo sapiens (human) | IC50 | 27.0533 | 1 | 15 |
| Caspase-5 | Homo sapiens (human) | IC50 | 27.0533 | 1 | 15 |
| Caspase-7 | Homo sapiens (human) | IC50 | 137.4000 | 1 | 1 |
| Caspase-9 | Homo sapiens (human) | IC50 | 27.0533 | 1 | 15 |
| Catechol O-methyltransferase | Homo sapiens (human) | IC50 | 147.1000 | 1 | 1 |
| Catechol O-methyltransferase | Rattus norvegicus (Norway rat) | IC50 | 147.1000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | IC50 | 31.0550 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | IC50 | 1.0000 | 1 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | Ki | 1.3275 | 1 | 2 |
| CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | IC50 | 4.8000 | 1 | 1 |
| Chain A, Chitinase | Clonostachys rosea | Ki | 19,700.0000 | 1 | 1 |
| Chain A, DEOXYNUCLEOSIDE KINASE | Drosophila melanogaster (fruit fly) | IC50 | 0.7600 | 1 | 1 |
| Chain A, Dihydrofolate reductase | Bacillus anthracis | IC50 | 77,200.0000 | 1 | 1 |
| Chain A, Dihydrofolate reductase | Homo sapiens (human) | Ki | 0.6050 | 1 | 4 |
| Chain A, dihydrofolate reductase (DHFR) | Bacillus anthracis | IC50 | 77,200.0000 | 1 | 1 |
| Chain A, Dipeptidyl peptidase IV | Homo sapiens (human) | IC50 | 0.0180 | 1 | 1 |
| Chain A, Endothiapepsin | Cryphonectria parasitica (chestnut blight fungus) | Ki | 0.0150 | 1 | 2 |
| Chain A, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Chain A, Glycogen Phosphorylase | Oryctolagus cuniculus (rabbit) | Ki | 100.0000 | 1 | 1 |
| Chain A, HIV-1 PROTEASE | Human immunodeficiency virus 1 | Ki | 0.0000 | 1 | 1 |
| Chain A, Inosine-5'-Monophosphate Dehydrogenase 2 | Cricetulus griseus (Chinese hamster) | Ki | 0.0060 | 1 | 1 |
| Chain A, Kemp eliminase KE59 R1 7/10H | Escherichia coli | Ki | 2.8200 | 1 | 1 |
| Chain A, Kemp eliminase KE59 R13 3/11H | Escherichia coli | Ki | 2.8200 | 1 | 2 |
| Chain A, membrane-associated prostaglandin E synthase-2 | Macaca fascicularis (crab-eating macaque) | IC50 | 1,000.0000 | 1 | 1 |
| Chain A, Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.0490 | 1 | 2 |
| Chain A, POL polyprotein | Human immunodeficiency virus 1 | Ki | 0.9320 | 1 | 2 |
| Chain A, Uracil Phosphoribosyltransferase | Toxoplasma gondii | Ki | 25.0000 | 1 | 1 |
| Chain B, HIV-1 PROTEASE | Human immunodeficiency virus 1 | Ki | 0.0000 | 1 | 1 |
| Chain B, POL polyprotein | Human immunodeficiency virus 1 | Ki | 0.9320 | 1 | 2 |
| Chain C, Cytochrome b | Bos taurus (cattle) | IC50 | 0.0112 | 1 | 2 |
| Chain C, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Chitotriosidase-1 | Homo sapiens (human) | IC50 | 363.0000 | 1 | 2 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | IC50 | 64.0000 | 1 | 1 |
| Cholecystokinin receptor type A | Homo sapiens (human) | IC50 | 5.0119 | 1 | 1 |
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | IC50 | 88.0000 | 3 | 3 |
| Cholecystokinin receptor type A | Cavia porcellus (domestic guinea pig) | Ki | 0.0600 | 1 | 1 |
| Cholinesterase | Equus caballus (horse) | IC50 | 10.0000 | 1 | 1 |
| Cholinesterase | Homo sapiens (human) | IC50 | 217.8667 | 3 | 3 |
| Chromaffin granule amine transporter | Homo sapiens (human) | IC50 | 0.0500 | 2 | 2 |
| Chymotrypsinogen A | Bos taurus (cattle) | IC50 | 242.5000 | 1 | 2 |
| Coagulation factor X | Homo sapiens (human) | IC50 | 10.4000 | 1 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | IC50 | 3.7600 | 1 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | IC50 | 3.7600 | 1 | 1 |
| Corticosteroid-binding globulin | Homo sapiens (human) | Ki | 0.0309 | 1 | 1 |
| Cruzipain | Trypanosoma cruzi | IC50 | 280.5000 | 2 | 2 |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | IC50 | 33.1720 | 1 | 1 |
| Cysteinyl leukotriene receptor 1 | Homo sapiens (human) | Ki | 16.5860 | 1 | 1 |
| Cystine/glutamate transporter | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Cytochrome b | Sus scrofa (pig) | Ki | 0.1535 | 1 | 3 |
| Cytochrome c oxidase subunit 2 | Homo sapiens (human) | IC50 | 3.5767 | 2 | 3 |
| Cytochrome P450 11B1, mitochondrial | Homo sapiens (human) | IC50 | 30.0000 | 1 | 1 |
| Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | IC50 | 13.0000 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | IC50 | 443.5000 | 8 | 10 |
| Cytochrome P450 2A13 | Homo sapiens (human) | Ki | 72.0000 | 1 | 1 |
| Cytochrome P450 2A5 | Mus musculus (house mouse) | IC50 | 119.9853 | 2 | 3 |
| Cytochrome P450 2A6 | Homo sapiens (human) | IC50 | 206.4030 | 3 | 5 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 46.2667 | 3 | 3 |
| Cytochrome P450 2C19 | Homo sapiens (human) | IC50 | 30.7714 | 7 | 10 |
| Cytochrome P450 2C8 | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 35.2975 | 12 | 33 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 50.0000 | 1 | 1 |
| Cytochrome P450 2D1 | Rattus norvegicus (Norway rat) | IC50 | 792.0000 | 1 | 2 |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | IC50 | 121.8000 | 1 | 2 |
| Cytochrome P450 2D3 | Rattus norvegicus (Norway rat) | IC50 | 2,053.8000 | 1 | 2 |
| Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | IC50 | 1,176.0000 | 1 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 24.6302 | 16 | 23 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.9600 | 1 | 1 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 36.8110 | 3 | 21 |
| Cytochrome P450 2J2 | Homo sapiens (human) | Ki | 0.1450 | 2 | 2 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 19.0441 | 26 | 36 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 615.7155 | 5 | 8 |
| Cytochrome P450 3A5 | Homo sapiens (human) | Ki | 0.1200 | 1 | 1 |
| Cytosolic phospholipase A2 gamma | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| D | Bos taurus (cattle) | IC50 | 4.0900 | 2 | 2 |
| D | Rattus norvegicus (Norway rat) | IC50 | 1.4267 | 8 | 13 |
| D | Bos taurus (cattle) | Ki | 0.4200 | 8 | 13 |
| D | Rattus norvegicus (Norway rat) | Ki | 0.3125 | 16 | 20 |
| D(1A) dopamine receptor | Homo sapiens (human) | IC50 | 3.6227 | 2 | 4 |
| D(1A) dopamine receptor | Homo sapiens (human) | Ki | 0.4257 | 12 | 15 |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.9312 | 5 | 7 |
| D(1B) dopamine receptor | Homo sapiens (human) | Ki | 0.3827 | 2 | 3 |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.2016 | 3 | 4 |
| D(2) dopamine receptor | Bos taurus (cattle) | IC50 | 1.8040 | 5 | 5 |
| D(2) dopamine receptor | Homo sapiens (human) | IC50 | 1.4411 | 10 | 14 |
| D(2) dopamine receptor | Mus musculus (house mouse) | IC50 | 0.2900 | 1 | 2 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.6687 | 23 | 29 |
| D(2) dopamine receptor | Bos taurus (cattle) | Ki | 0.3850 | 2 | 2 |
| D(2) dopamine receptor | Chlorocebus aethiops (grivet) | Ki | 0.2540 | 2 | 2 |
| D(2) dopamine receptor | Homo sapiens (human) | Ki | 0.3036 | 71 | 79 |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.1971 | 32 | 46 |
| D(3) dopamine receptor | Homo sapiens (human) | IC50 | 20.7526 | 2 | 7 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 64.5648 | 6 | 8 |
| D(3) dopamine receptor | Chlorocebus aethiops (grivet) | Ki | 0.4660 | 1 | 1 |
| D(3) dopamine receptor | Homo sapiens (human) | Ki | 1.5293 | 35 | 43 |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.8884 | 7 | 8 |
| D(4) dopamine receptor | Homo sapiens (human) | IC50 | 1.6057 | 13 | 13 |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | IC50 | 0.9312 | 5 | 7 |
| D(4) dopamine receptor | Homo sapiens (human) | Ki | 0.3333 | 52 | 52 |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | Ki | 0.1414 | 5 | 6 |
| Dehydrogenase/reductase SDR family member 9 | Homo sapiens (human) | IC50 | 14.0000 | 1 | 1 |
| Dehydrogenase/reductase SDR family member 9 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 6.7350 | 1 | 2 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 0.8856 | 16 | 23 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 1.7724 | 9 | 19 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1751 | 14 | 21 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 0.7892 | 64 | 82 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 1.8555 | 11 | 14 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.3313 | 22 | 28 |
| Diamine acetyltransferase 1 | Homo sapiens (human) | Ki | 2.0000 | 1 | 1 |
| Dihydrofolate reductase | Candida albicans | IC50 | 24.5144 | 5 | 5 |
| Dihydrofolate reductase | Escherichia coli K-12 | IC50 | 267.1549 | 33 | 46 |
| Dihydrofolate reductase | Gallus gallus (chicken) | IC50 | 493.3333 | 3 | 3 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 205.3070 | 44 | 62 |
| Dihydrofolate reductase | Lacticaseibacillus casei | IC50 | 0.3492 | 4 | 4 |
| Dihydrofolate reductase | Lactococcus lactis subsp. lactis Il1403 | IC50 | 0.4500 | 1 | 1 |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | IC50 | 88.0000 | 1 | 1 |
| Dihydrofolate reductase | Neisseria gonorrhoeae | IC50 | 0.4500 | 2 | 2 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 262.5425 | 41 | 53 |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | IC50 | 3,261.4521 | 48 | 58 |
| Dihydrofolate reductase | Saccharomyces cerevisiae S288C | IC50 | 12.0000 | 1 | 1 |
| Dihydrofolate reductase | Staphylococcus aureus | IC50 | 982.6437 | 10 | 17 |
| Dihydrofolate reductase | Streptococcus pneumoniae TIGR4 | IC50 | 64.1815 | 2 | 6 |
| Dihydrofolate reductase | Escherichia coli K-12 | Ki | 1.6948 | 9 | 9 |
| Dihydrofolate reductase | Gallus gallus (chicken) | Ki | 104.7130 | 2 | 2 |
| Dihydrofolate reductase | Homo sapiens (human) | Ki | 1,525.3846 | 13 | 17 |
| Dihydrofolate reductase | Lacticaseibacillus casei | Ki | 0.1318 | 1 | 1 |
| Dihydrofolate reductase | Mus musculus (house mouse) | Ki | 0.5000 | 1 | 1 |
| Dihydrofolate reductase | Pneumocystis carinii | Ki | 93.4345 | 3 | 3 |
| Dihydrofolate reductase | Staphylococcus aureus | Ki | 0.2115 | 13 | 13 |
| Dihydrofolate reductase | Bacillus anthracis | IC50 | 45.7880 | 5 | 5 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 6,309.5700 | 1 | 1 |
| Dihydrofolate reductase | Mycobacterium avium | IC50 | 33.5633 | 9 | 9 |
| Dihydrofolate reductase | Pneumocystis jirovecii | IC50 | 0.0920 | 1 | 1 |
| Dihydrofolate reductase | Bacillus anthracis | Ki | 12.7600 | 3 | 3 |
| Dihydrofolate reductase | Salmonella enterica subsp. enterica serovar Typhi | Ki | 0.0083 | 1 | 1 |
| Dihydrofolate reductase type 1 | Escherichia coli | IC50 | 0.2500 | 2 | 2 |
| Dihydrofolate reductase type 1 from Tn4003 | Staphylococcus aureus | IC50 | 109.5308 | 1 | 4 |
| Dihydropteroate synthase | Escherichia coli K-12 | IC50 | 3.6000 | 1 | 2 |
| Dipeptidase 1 | Sus scrofa (pig) | Ki | 0.1700 | 1 | 3 |
| Dipeptidyl peptidase 2 | Homo sapiens (human) | IC50 | 94.5698 | 18 | 24 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 6.7636 | 60 | 66 |
| Dipeptidyl peptidase 4 | Mus musculus (house mouse) | IC50 | 50.0230 | 2 | 2 |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | IC50 | 0.9170 | 3 | 3 |
| Dipeptidyl peptidase 4 | Sus scrofa (pig) | IC50 | 175.1000 | 1 | 1 |
| Dipeptidyl peptidase 8 | Homo sapiens (human) | IC50 | 44.8279 | 24 | 30 |
| Dipeptidyl peptidase 9 | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Dipeptidyl peptidase 9 | Homo sapiens (human) | IC50 | 82.0785 | 19 | 22 |
| Dipeptidyl peptidase IV | Porphyromonas gingivalis | IC50 | 18.0000 | 1 | 1 |
| DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 6.3000 | 1 | 1 |
| DNA gyrase subunit A | Escherichia coli K-12 | IC50 | 40.1596 | 28 | 29 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 19.4418 | 3 | 3 |
| DNA gyrase subunit A | Staphylococcus aureus | IC50 | 103.4485 | 20 | 20 |
| DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 6.3000 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | IC50 | 42.9595 | 23 | 24 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 24.1628 | 2 | 2 |
| DNA gyrase subunit B | Staphylococcus aureus | IC50 | 57.9980 | 15 | 15 |
| DNA topoisomerase 1 | Homo sapiens (human) | IC50 | 160.0000 | 1 | 1 |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | IC50 | 169.8667 | 3 | 3 |
| DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 1.7000 | 1 | 1 |
| DNA topoisomerase 4 subunit A | Escherichia coli K-12 | IC50 | 51.0000 | 1 | 1 |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | IC50 | 5.4282 | 10 | 11 |
| DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 1.7000 | 1 | 1 |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | IC50 | 6.4850 | 6 | 6 |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Ecdysone receptor | Aedes aegypti (yellow fever mosquito) | Ki | 0.0251 | 1 | 1 |
| Ecdysone receptor | Chironomus tentans | Ki | 0.0100 | 1 | 1 |
| Ecdysone receptor | Drosophila melanogaster (fruit fly) | Ki | 0.2512 | 1 | 1 |
| Ecdysone receptor | Heliothis virescens (tobacco budworm) | Ki | 0.0032 | 1 | 1 |
| Ecdysone receptor | Lucilia cuprina (Australian sheep blowfly) | Ki | 0.1585 | 1 | 1 |
| Ecdysone receptor | Bemisia tabaci | Ki | 501.1870 | 1 | 1 |
| Ecdysone receptor | Myzus persicae (green peach aphid) | Ki | 125.8930 | 1 | 1 |
| Endochitinase B1 | Aspergillus fumigatus | IC50 | 363.0000 | 1 | 2 |
| Endoplasmic reticulum chaperone BiP | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Endothelin receptor type B | Homo sapiens (human) | Ki | 0.0126 | 2 | 2 |
| Endothelin receptor type B | Rattus norvegicus (Norway rat) | Ki | 0.0126 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | IC50 | 37.0059 | 2 | 2 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 184.7500 | 3 | 4 |
| Endothelin-1 receptor | Homo sapiens (human) | Ki | 6.6667 | 3 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | IC50 | 2.8712 | 8 | 8 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | Ki | 0.2100 | 4 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Francisella tularensis subsp. tularensis SCHU S4 | IC50 | 16.7750 | 6 | 6 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 0.5000 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | IC50 | 2.9579 | 8 | 12 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Haemophilus influenzae Rd KW20 | IC50 | 7.6425 | 2 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | IC50 | 2.6049 | 10 | 14 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | Ki | 0.0000 | 1 | 1 |
| Enoyl-ACP reductase II | Streptococcus pneumoniae | IC50 | 32.0000 | 2 | 2 |
| Enoyl-acyl carrier reductase | Toxoplasma gondii | IC50 | 0.0167 | 3 | 3 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.0873 | 8 | 8 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0554 | 17 | 17 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 17.1696 | 3 | 6 |
| Epoxide hydrolase B | Mycobacterium tuberculosis CDC1551 | IC50 | 0.2200 | 2 | 2 |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | IC50 | 0.1900 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 18.6726 | 8 | 8 |
| Estrogen receptor | Homo sapiens (human) | Ki | 2.5498 | 5 | 5 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 41.8117 | 6 | 6 |
| Estrogen receptor beta | Homo sapiens (human) | Ki | 1.0000 | 1 | 1 |
| Estrogen-related receptor gamma | Homo sapiens (human) | IC50 | 0.0090 | 2 | 2 |
| exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | IC50 | 96.2613 | 2 | 3 |
| exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | IC50 | 96.2613 | 2 | 3 |
| exodeoxyribonuclease V subunit RecD | Escherichia coli str. K-12 substr. MG1655 | IC50 | 96.2613 | 2 | 3 |
| Fatty acid synthase | Homo sapiens (human) | IC50 | 36.2000 | 1 | 1 |
| Fatty acid synthase | Homo sapiens (human) | Ki | 4.1000 | 1 | 1 |
| Fatty acid-binding protein, heart | Homo sapiens (human) | IC50 | 0.3670 | 1 | 1 |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | Ki | 94.2600 | 2 | 5 |
| Fatty acid-binding protein, liver | Homo sapiens (human) | Ki | 0.0433 | 1 | 3 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 101.0247 | 3 | 15 |
| Fatty-acid amide hydrolase 1 | Homo sapiens (human) | IC50 | 0.2645 | 2 | 2 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 460.4154 | 4 | 5 |
| Forkhead box protein A2-A | Xenopus laevis (African clawed frog) | Ki | 0.0019 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | Ki | 3.2700 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | IC50 | 0.0670 | 1 | 1 |
| Gag-Pol polyprotein | HIV-1 M:B_ARV2/SF2 | Ki | 0.0021 | 1 | 3 |
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | Ki | 0.3932 | 2 | 12 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | Ki | 0.0043 | 3 | 15 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (RF/HAT ISOLATE) | Ki | 0.0069 | 1 | 6 |
| Gag-Pol polyprotein | Human immunodeficiency virus type 1 (STRAIN UGANDAN / ISOLATE U455) | Ki | 0.0069 | 1 | 6 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 0.0122 | 14 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.4433 | 21 | 23 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 0.0151 | 12 | 13 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0089 | 16 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 0.0175 | 13 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0090 | 18 | 20 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | IC50 | 24,744.4074 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 0.0103 | 9 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 0.0076 | 16 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 3.4040 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 0.8207 | 19 | 21 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 0.0107 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 0.8833 | 12 | 16 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.8300 | 31 | 33 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | IC50 | 24,744.4074 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 0.1159 | 30 | 30 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 0.0074 | 15 | 17 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 6.2072 | 27 | 42 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | IC50 | 0.0266 | 3 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | IC50 | 24,744.4074 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Bos taurus (cattle) | Ki | 0.0100 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 0.3912 | 41 | 45 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 0.7832 | 33 | 35 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 6.4924 | 26 | 40 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 13 | 15 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | IC50 | 30,930.5050 | 4 | 4 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 0.0100 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | Ki | 85.0000 | 1 | 3 |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Gastrin/cholecystokinin type B receptor | Mus musculus (house mouse) | Ki | 0.0038 | 1 | 2 |
| Gene regulation protein | Heliothis virescens (tobacco budworm) | Ki | 0.0032 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.5359 | 45 | 48 |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0565 | 3 | 3 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.1283 | 16 | 19 |
| Glucose-6-phosphate 1-dehydrogenase | Homo sapiens (human) | Ki | 187.4000 | 1 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | Homo sapiens (human) | IC50 | 59.3000 | 1 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | IC50 | 38.7167 | 3 | 3 |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.0140 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | IC50 | 3.2668 | 5 | 6 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | Ki | 0.7567 | 5 | 6 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | IC50 | 4.2160 | 5 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | Ki | 0.8308 | 18 | 18 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | IC50 | 2.8472 | 3 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | Ki | 0.7567 | 5 | 6 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | IC50 | 4.2160 | 5 | 5 |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | Ki | 0.8691 | 17 | 17 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | IC50 | 4.1059 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | IC50 | 5.0200 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | Ki | 0.8720 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | Ki | 0.8691 | 17 | 17 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | IC50 | 5.0200 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | Ki | 0.8720 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | Ki | 0.9122 | 16 | 16 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | IC50 | 5.0200 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | Ki | 0.8720 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | Ki | 0.9122 | 16 | 16 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | IC50 | 5.0200 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | Ki | 0.8720 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | Ki | 0.9122 | 16 | 16 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | IC50 | 5.0200 | 4 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | Ki | 0.8720 | 4 | 5 |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | Ki | 0.9122 | 16 | 16 |
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 1.2969 | 1 | 4 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.5896 | 1 | 4 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 1.2969 | 1 | 4 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.5896 | 1 | 4 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 1.2969 | 1 | 4 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.5896 | 1 | 4 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 1.2969 | 1 | 4 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.5896 | 1 | 4 |
| Glycogen phosphorylase, liver form | Rattus norvegicus (Norway rat) | IC50 | 648.0000 | 1 | 1 |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | IC50 | 159.1933 | 13 | 15 |
| Glycogen phosphorylase, muscle form | Rattus norvegicus (Norway rat) | IC50 | 182.0000 | 1 | 1 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Guanine deaminase | Homo sapiens (human) | Ki | 10.2000 | 1 | 1 |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | IC50 | 78.7500 | 1 | 4 |
| Heme oxygenase 2 | Rattus norvegicus (Norway rat) | IC50 | 78.7500 | 1 | 4 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | IC50 | 60.0000 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | IC50 | 9.8052 | 1 | 3 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0115 | 2 | 4 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0126 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | Ki | 0.1756 | 19 | 22 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | Ki | 0.0050 | 1 | 2 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.6600 | 1 | 1 |
| Histamine H2 receptor | Homo sapiens (human) | IC50 | 3.1683 | 1 | 3 |
| Histamine H2 receptor | Homo sapiens (human) | Ki | 3.1157 | 1 | 3 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 0.8770 | 2 | 3 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 4.1155 | 3 | 5 |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 2,500,000.0000 | 1 | 1 |
| Histone acetyltransferase KAT8 | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Histone deacetylase 1 | Homo sapiens (human) | IC50 | 25.8095 | 2 | 2 |
| Histone deacetylase 11 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 2 | Homo sapiens (human) | IC50 | 31.2735 | 2 | 2 |
| Histone deacetylase 3 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 4 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 5 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 6 | Homo sapiens (human) | IC50 | 27.2330 | 2 | 2 |
| Histone deacetylase 7 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 8 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Histone deacetylase 9 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Holo-[acyl-carrier-protein] synthase | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 12.7000 | 1 | 1 |
| Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | IC50 | 2.2250 | 1 | 2 |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | IC50 | 644.7560 | 4 | 5 |
| Indoleamine 2,3-dioxygenase 1 | Mus musculus (house mouse) | IC50 | 32.1928 | 3 | 5 |
| Indoleamine 2,3-dioxygenase 2 | Mus musculus (house mouse) | IC50 | 9.2500 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase | Cryptococcus neoformans var. neoformans JEC21 | IC50 | 0.1200 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | IC50 | 3.3977 | 6 | 6 |
| Inosine-5'-monophosphate dehydrogenase 1 | Homo sapiens (human) | Ki | 0.0365 | 8 | 8 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | IC50 | 1.1421 | 20 | 20 |
| Inosine-5'-monophosphate dehydrogenase 2 | Homo sapiens (human) | Ki | 0.0084 | 8 | 8 |
| Insulin receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0029 | 1 | 2 |
| Integrase | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 1 |
| Integrin alpha-5 | Homo sapiens (human) | IC50 | 1.8000 | 1 | 1 |
| Interleukin-8 | Homo sapiens (human) | IC50 | 0.0290 | 1 | 2 |
| Intermediate conductance calcium-activated potassium channel protein 4 | Homo sapiens (human) | IC50 | 0.1667 | 3 | 3 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.4042 | 11 | 14 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 2.4889 | 12 | 17 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | IC50 | 3.7921 | 3 | 8 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0410 | 10 | 12 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 2.2444 | 39 | 54 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 0.6156 | 52 | 59 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | Ki | 0.3102 | 5 | 6 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.0351 | 6 | 7 |
| Krueppel-like factor 10 | Homo sapiens (human) | IC50 | 100.0000 | 2 | 2 |
| Kynurenine 3-monooxygenase | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Lactoperoxidase | Bos taurus (cattle) | IC50 | 5.0000 | 1 | 1 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 361.1000 | 3 | 6 |
| Lanosterol 14-alpha demethylase | Candida albicans SC5314 | IC50 | 0.1296 | 5 | 5 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | IC50 | 133.3767 | 1 | 3 |
| large T antigen | Betapolyomavirus macacae | IC50 | 32.3000 | 1 | 1 |
| Leukotriene B4 receptor 1 | Homo sapiens (human) | Ki | 0.5240 | 1 | 1 |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | Ki | 0.5240 | 1 | 1 |
| likely tRNA 2'-phosphotransferase | Candida albicans SC5314 | IC50 | 49.7510 | 1 | 1 |
| Liver carboxylesterase B-1 | Rattus norvegicus (Norway rat) | IC50 | 7.0225 | 1 | 2 |
| Lysosomal Pro-X carboxypeptidase | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Malate dehydrogenase, cytoplasmic | Homo sapiens (human) | IC50 | 220.0000 | 1 | 3 |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | IC50 | 2.7300 | 1 | 1 |
| Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.0317 | 18 | 18 |
| Mineralocorticoid receptor | Homo sapiens (human) | Ki | 0.0112 | 4 | 4 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 43.1930 | 1 | 1 |
| Monoglyceride lipase | Rattus norvegicus (Norway rat) | IC50 | 0.1972 | 2 | 2 |
| MPI protein | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.7232 | 9 | 9 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 2.5101 | 25 | 31 |
| Mu-type opioid receptor | Mus musculus (house mouse) | IC50 | 40.3087 | 11 | 17 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0314 | 13 | 16 |
| Mu-type opioid receptor | Bos taurus (cattle) | Ki | 0.0013 | 3 | 3 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.1574 | 33 | 49 |
| Mu-type opioid receptor | Danio rerio (zebrafish) | Ki | 0.1872 | 2 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 0.4704 | 65 | 77 |
| Mu-type opioid receptor | Mus musculus (house mouse) | Ki | 0.0262 | 16 | 19 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.4365 | 29 | 45 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 185.9439 | 3 | 18 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 97.4000 | 2 | 6 |
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | IC50 | 12.3000 | 2 | 2 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 123.0267 | 1 | 55 |
| Muscarinic acetylcholine receptor DM1 | Drosophila melanogaster (fruit fly) | Ki | 100.0000 | 2 | 2 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | IC50 | 1.9868 | 4 | 6 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | IC50 | 55.5433 | 6 | 13 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | Ki | 0.2130 | 6 | 8 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 12.3016 | 6 | 10 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | IC50 | 4.3050 | 2 | 5 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | IC50 | 40.1852 | 6 | 9 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | Ki | 1.1812 | 2 | 5 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 1.1403 | 5 | 9 |
| Muscarinic acetylcholine receptor M2 | Sus scrofa (pig) | Ki | 0.2344 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | IC50 | 3.7610 | 2 | 4 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | IC50 | 40.1852 | 6 | 9 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | Ki | 0.5401 | 2 | 4 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 0.0310 | 3 | 7 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | IC50 | 3.3466 | 1 | 4 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | IC50 | 40.1852 | 6 | 9 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | Ki | 0.3189 | 3 | 6 |
| Muscarinic acetylcholine receptor M4 | Mus musculus (house mouse) | Ki | 2.1100 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 0.2596 | 5 | 9 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | IC50 | 0.9687 | 1 | 3 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | IC50 | 40.1852 | 6 | 9 |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | Ki | 0.5306 | 2 | 4 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 0.0310 | 3 | 7 |
| Myc proto-oncogene protein | Homo sapiens (human) | IC50 | 403.0000 | 1 | 1 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 2.1350 | 2 | 4 |
| Myoglobin | Homo sapiens (human) | IC50 | 2.3000 | 1 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | Homo sapiens (human) | IC50 | 38.1000 | 1 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | Mus musculus (house mouse) | IC50 | 15.9200 | 2 | 2 |
| Neprilysin | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Aichi/2/1968(H3N2)) | IC50 | 0.0016 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 | 1.1344 | 6 | 6 |
| Neuraminidase | Influenza A virus (A/Singapore/1/1957(H2N2)) | IC50 | 0.0030 | 1 | 2 |
| Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | IC50 | 27.1760 | 4 | 4 |
| Neuraminidase | Influenza B virus (B/Lee/1940) | IC50 | 0.0050 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | Ki | 12.1000 | 1 | 1 |
| Neuraminidase | Influenza B virus (B/Lee/1940) | Ki | 0.0011 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) | IC50 | 0.0043 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/duck/Laos/25/2006(H5N1)) | IC50 | 2.0317 | 3 | 3 |
| Neuraminidase | Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) | IC50 | 0.0002 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/Turkey/651242/2006(H5N1)) | IC50 | 0.1104 | 2 | 2 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 | 13.0076 | 82 | 83 |
| Neuraminidase | Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) | Ki | 0.0049 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/duck/Laos/25/2006(H5N1)) | Ki | 0.0011 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) | Ki | 0.0001 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Turkey/651242/2006(H5N1)) | Ki | 0.0079 | 1 | 1 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | Ki | 0.0005 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-10 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-10 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 3 | 4 |
| Neuronal acetylcholine receptor subunit alpha-2 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens (human) | Ki | 0.0595 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 0.0012 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0438 | 27 | 28 |
| Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | IC50 | 2.1601 | 10 | 11 |
| Neuronal acetylcholine receptor subunit alpha-3 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 6.2120 | 5 | 5 |
| Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | Ki | 0.3763 | 20 | 20 |
| Neuronal acetylcholine receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 0.0841 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.2178 | 37 | 42 |
| Neuronal acetylcholine receptor subunit alpha-4 | Gallus gallus (chicken) | IC50 | 1.7300 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | IC50 | 3.5355 | 17 | 19 |
| Neuronal acetylcholine receptor subunit alpha-4 | Mus musculus (house mouse) | IC50 | 0.8678 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 0.0044 | 4 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | Gallus gallus (chicken) | Ki | 0.4730 | 1 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | Ki | 0.3565 | 30 | 31 |
| Neuronal acetylcholine receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 0.0012 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 0.0206 | 74 | 87 |
| Neuronal acetylcholine receptor subunit alpha-5 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 0.0012 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 3 | 4 |
| Neuronal acetylcholine receptor subunit alpha-6 | Homo sapiens (human) | IC50 | 0.0848 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 0.0012 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 3 | 4 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | IC50 | 76.0833 | 4 | 6 |
| Neuronal acetylcholine receptor subunit alpha-7 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | IC50 | 0.0087 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | Ki | 5.9317 | 17 | 19 |
| Neuronal acetylcholine receptor subunit alpha-7 | Mus musculus (house mouse) | Ki | 0.2406 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | Ki | 3.4980 | 17 | 21 |
| Neuronal acetylcholine receptor subunit alpha-9 | Rattus norvegicus (Norway rat) | IC50 | 0.0041 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-9 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 3 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | IC50 | 2.2655 | 17 | 19 |
| Neuronal acetylcholine receptor subunit beta-2 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0044 | 4 | 4 |
| Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | Ki | 0.3522 | 30 | 31 |
| Neuronal acetylcholine receptor subunit beta-2 | Mus musculus (house mouse) | Ki | 0.0024 | 2 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 0.0124 | 77 | 86 |
| Neuronal acetylcholine receptor subunit beta-3 | Homo sapiens (human) | IC50 | 0.0848 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0050 | 2 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 0.0012 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 0.0070 | 3 | 4 |
| Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | IC50 | 3.5647 | 10 | 10 |
| Neuronal acetylcholine receptor subunit beta-4 | Mus musculus (house mouse) | IC50 | 0.0040 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | IC50 | 6.2120 | 5 | 5 |
| Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | Ki | 0.3463 | 22 | 22 |
| Neuronal acetylcholine receptor subunit beta-4 | Mus musculus (house mouse) | Ki | 0.0572 | 3 | 3 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | Ki | 0.1748 | 54 | 63 |
| NH(3)-dependent NAD(+) synthetase | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 1.0000 | 1 | 1 |
| Nicotinate phosphoribosyltransferase | Homo sapiens (human) | Ki | 0.0006 | 1 | 4 |
| Nicotinic acetyl choline receptor alpha-subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nicotinic acetylcholine receptor | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha 3 subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha 4 subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha 5 subunit | Musca domestica (house fly) | Ki | 0.0046 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha3, isoform B | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha4, isoform D | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha5, isoform B | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor alpha6, isoform E | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor beta 3 | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor Dalpha7 | Drosophila melanogaster (fruit fly) | Ki | 0.0021 | 1 | 1 |
| Nicotinic acetylcholine receptor, alpha5 subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nicotinic acetylcholine receptor, alpha7-1 subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nicotinic acetylcholine receptor, alpha7-2 subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | IC50 | 24.3500 | 5 | 5 |
| NLRP3 protein | Homo sapiens (human) | IC50 | 1.1475 | 2 | 2 |
| Nociceptin receptor | Homo sapiens (human) | IC50 | 5.0000 | 1 | 1 |
| Nociceptin receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0025 | 1 | 1 |
| Nociceptin receptor | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Nuclear receptor RXR-l | Locusta migratoria (migratory locust) | Ki | 100.0000 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 3 | Homo sapiens (human) | IC50 | 0.2900 | 3 | 3 |
| Nuclear receptor subfamily 1 group I member 3 | Homo sapiens (human) | Ki | 0.1000 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 14.6273 | 1 | 3 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 11.9838 | 1 | 3 |
| Opioid receptor homologue | Danio rerio (zebrafish) | Ki | 0.2230 | 1 | 1 |
| Opioid receptor, delta 1b | Danio rerio (zebrafish) | Ki | 1.4270 | 1 | 1 |
| P2X purinoceptor 4 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| P2Y purinoceptor 12 | Homo sapiens (human) | IC50 | 7,430.0000 | 1 | 1 |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | IC50 | 0.4900 | 1 | 2 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | IC50 | 18.6000 | 1 | 1 |
| Pantothenate synthetase | Mycobacterium tuberculosis H37Rv | IC50 | 25.0000 | 3 | 3 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | IC50 | 7.0000 | 3 | 3 |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | IC50 | 1.1500 | 1 | 1 |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | IC50 | 6.0465 | 10 | 10 |
| Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | IC50 | 0.7000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Rattus norvegicus (Norway rat) | IC50 | 0.7000 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Ki | 0.5761 | 8 | 8 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | IC50 | 3,630.0000 | 1 | 1 |
| Phosphodiesterase | Rattus norvegicus (Norway rat) | IC50 | 70.0000 | 1 | 1 |
| Phospholipase A2, major isoenzyme | Sus scrofa (pig) | IC50 | 1,000.0000 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Photosystem II protein D1 | Spinacia oleracea (spinach) | IC50 | 0.7499 | 2 | 3 |
| Plasmepsin V | Plasmodium falciparum 3D7 | IC50 | 20.0000 | 1 | 1 |
| Plasminogen | Homo sapiens (human) | IC50 | 28.4000 | 3 | 5 |
| Platelet-activating factor receptor | Homo sapiens (human) | IC50 | 35.0380 | 1 | 1 |
| Platelet-activating factor receptor | Homo sapiens (human) | Ki | 22.6350 | 1 | 1 |
| polyadenylate-binding protein 1 | Homo sapiens (human) | IC50 | 66.0000 | 2 | 2 |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 965.0000 | 3 | 6 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 0.5850 | 2 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 498.5000 | 6 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | IC50 | 10.4500 | 1 | 3 |
| Potassium channel subfamily K member 18 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | IC50 | 193.5000 | 2 | 2 |
| Potassium channel subfamily K member 3 | Homo sapiens (human) | IC50 | 222.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | IC50 | 2,188.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | IC50 | 1,210.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily D member 3 | Homo sapiens (human) | IC50 | 100,000.0000 | 1 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | Homo sapiens (human) | IC50 | 237.3585 | 2 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 158.6285 | 36 | 83 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 22.1364 | 6 | 8 |
| Potassium voltage-gated channel subfamily KQT member 1 | Homo sapiens (human) | IC50 | 237.3585 | 2 | 2 |
| Potassium-transporting ATPase alpha chain 1 | Sus scrofa (pig) | IC50 | 5.2000 | 1 | 1 |
| Potassium-transporting ATPase subunit beta | Sus scrofa (pig) | IC50 | 5.2000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | IC50 | 11.8000 | 1 | 1 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 4.7982 | 11 | 11 |
| Progesterone receptor | Homo sapiens (human) | Ki | 4.8000 | 8 | 8 |
| Prolyl endopeptidase | Homo sapiens (human) | IC50 | 100.0000 | 2 | 2 |
| Prolyl endopeptidase FAP | Homo sapiens (human) | IC50 | 52.6136 | 11 | 14 |
| Prolyl endopeptidase FAP | Mus musculus (house mouse) | IC50 | 100.0000 | 1 | 1 |
| Prostaglandin D2 receptor | Mus musculus (house mouse) | IC50 | 10.0000 | 1 | 1 |
| Prostaglandin D2 receptor | Mus musculus (house mouse) | Ki | 10.0000 | 2 | 2 |
| Prostaglandin D2 receptor 2 | Homo sapiens (human) | Ki | 4.0250 | 2 | 2 |
| Prostaglandin E synthase | Homo sapiens (human) | IC50 | 40.6000 | 1 | 1 |
| Prostaglandin E2 receptor EP1 subtype | Mus musculus (house mouse) | Ki | 10.0000 | 2 | 2 |
| Prostaglandin E2 receptor EP2 subtype | Mus musculus (house mouse) | Ki | 10.0000 | 2 | 2 |
| Prostaglandin E2 receptor EP3 subtype | Mus musculus (house mouse) | Ki | 10.0000 | 2 | 2 |
| Prostaglandin E2 receptor EP4 subtype | Mus musculus (house mouse) | Ki | 10.0000 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 4.6494 | 77 | 99 |
| Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | IC50 | 0.0807 | 2 | 3 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 6.4116 | 112 | 162 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | Ki | 8.4500 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 103.1725 | 14 | 22 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 0.6348 | 9 | 11 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 19.2632 | 137 | 188 |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | IC50 | 1.0058 | 19 | 29 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 103.8620 | 34 | 46 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Ki | 3.8333 | 2 | 3 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | Ki | 9.4300 | 2 | 2 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 0.8088 | 7 | 10 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 0.6375 | 9 | 11 |
| Prostaglandin-H2 D-isomerase | Mus musculus (house mouse) | IC50 | 1.1000 | 2 | 2 |
| Protease | Human immunodeficiency virus 1 | IC50 | 4.9253 | 2 | 2 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0077 | 17 | 18 |
| Proteasome subunit beta type-5 | Homo sapiens (human) | IC50 | 25.0000 | 1 | 1 |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | IC50 | 224.0000 | 3 | 3 |
| Protein arginine N-methyltransferase 5 | Homo sapiens (human) | IC50 | 582.0000 | 1 | 1 |
| Protein arginine N-methyltransferase 6 | Homo sapiens (human) | IC50 | 430.0000 | 1 | 1 |
| Protein phosphatase 1A | Homo sapiens (human) | IC50 | 0.0030 | 1 | 1 |
| Protein S100-B | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Protein tyrosine phosphatase type IVA 1 | Homo sapiens (human) | IC50 | 0.3000 | 1 | 1 |
| Protein tyrosine phosphatase type IVA 2 | Homo sapiens (human) | IC50 | 0.3000 | 1 | 1 |
| Protein tyrosine phosphatase type IVA 3 | Homo sapiens (human) | IC50 | 35.8333 | 3 | 3 |
| Protein ultraspiracle | Drosophila melanogaster (fruit fly) | Ki | 0.2512 | 1 | 1 |
| Protein ultraspiracle homolog | Choristoneura fumiferana (eastern spruce budworm) | Ki | 0.0005 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 9,375.0000 | 1 | 4 |
| Proteinase-activated receptor 1 | Homo sapiens (human) | Ki | 0.0022 | 1 | 1 |
| Putative nicotinic acetylcholine receptor subunit | Myzus persicae (green peach aphid) | Ki | 0.0019 | 1 | 1 |
| Quinolone resistance protein NorA | Staphylococcus aureus | IC50 | 8.5429 | 7 | 7 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | IC50 | 36.1761 | 1 | 2 |
| Renin | Homo sapiens (human) | Ki | 15.0000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 35.9533 | 3 | 6 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 47.9500 | 1 | 4 |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | IC50 | 7.7000 | 1 | 2 |
| RmtA | Aspergillus nidulans | IC50 | 510.0000 | 1 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | IC50 | 117.5000 | 2 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | Ki | 35.0000 | 1 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 130.0000 | 1 | 1 |
| Serine-protein kinase ATM | Homo sapiens (human) | IC50 | 200.0000 | 1 | 1 |
| Serine/threonine-protein kinase ATR | Homo sapiens (human) | IC50 | 1,100.0000 | 1 | 1 |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | IC50 | 400.0000 | 1 | 1 |
| Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Gallus gallus (chicken) | IC50 | 0.0016 | 2 | 2 |
| Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform | Homo sapiens (human) | IC50 | 0.0001 | 1 | 1 |
| Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Homo sapiens (human) | IC50 | 0.0302 | 10 | 10 |
| Serum paraoxonase/arylesterase 1 | Homo sapiens (human) | Ki | 5,695.5000 | 3 | 4 |
| Sialidase | Clostridium perfringens | IC50 | 61.1000 | 1 | 1 |
| Sialidase-1 | Homo sapiens (human) | IC50 | 3,666.6667 | 3 | 3 |
| Sialidase-2 | Homo sapiens (human) | IC50 | 2,333.3333 | 3 | 3 |
| Sialidase-3 | Homo sapiens (human) | IC50 | 5,250.0000 | 4 | 4 |
| Sialidase-4 | Homo sapiens (human) | IC50 | 3,666.6667 | 3 | 3 |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | IC50 | 500.2450 | 2 | 2 |
| Sigma intracellular receptor 2 | Homo sapiens (human) | Ki | 0.2000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | IC50 | 0.1236 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | IC50 | 1.5002 | 2 | 4 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | IC50 | 5.5000 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | Ki | 0.0365 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 15.9671 | 7 | 8 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | Ki | 5.0700 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 78.3556 | 3 | 9 |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | IC50 | 71.3333 | 3 | 3 |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 30.0200 | 5 | 5 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 70.4727 | 5 | 11 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 15.8333 | 3 | 3 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 78.3556 | 3 | 9 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 624.4064 | 5 | 5 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | Ki | 34.5000 | 1 | 2 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 195.4217 | 9 | 9 |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | IC50 | 20.0000 | 1 | 1 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 13.7357 | 7 | 7 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | Ki | 32.7000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 10.0667 | 2 | 3 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 10.0667 | 2 | 3 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 10.0667 | 2 | 3 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 10.0667 | 2 | 3 |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | IC50 | 0.2000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 1.6342 | 50 | 74 |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | Ki | 0.8500 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 22.0712 | 30 | 47 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 2.2826 | 58 | 65 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 1.3310 | 35 | 46 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 2.0349 | 51 | 61 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 2.5387 | 34 | 46 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 5.4554 | 45 | 53 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 1.0780 | 19 | 22 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 0.8029 | 39 | 52 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | Ki | 0.4713 | 22 | 32 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | IC50 | 16.8333 | 2 | 3 |
| Sodium/bile acid cotransporter | Homo sapiens (human) | Ki | 15.1500 | 1 | 2 |
| Sodium/hydrogen exchanger 1 | Homo sapiens (human) | IC50 | 192.6800 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | Homo sapiens (human) | IC50 | 199.5260 | 1 | 1 |
| Soluble acetylcholine receptor | Aplysia californica (California sea hare) | Ki | 0.5325 | 3 | 6 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | Ki | 42.1500 | 2 | 2 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 257.5722 | 6 | 18 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | IC50 | 591.0000 | 1 | 1 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 431.8750 | 2 | 4 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | Ki | 50.5000 | 1 | 1 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 1.1110 | 1 | 2 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | IC50 | 148.8333 | 1 | 3 |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | IC50 | 248.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | IC50 | 372.6875 | 3 | 8 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | IC50 | 1,193.7500 | 2 | 2 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 1,470.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 4.6887 | 1 | 2 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 386.6889 | 5 | 9 |
| Solute carrier family 22 member 7 | Homo sapiens (human) | IC50 | 352.0000 | 1 | 1 |
| Solute carrier family 22 member 7 | Rattus norvegicus (Norway rat) | IC50 | 449.0000 | 1 | 1 |
| Solute carrier family 22 member 7 | Rattus norvegicus (Norway rat) | Ki | 1.8400 | 1 | 1 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | IC50 | 131.3500 | 1 | 2 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | IC50 | 378.8000 | 1 | 2 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 641.7375 | 2 | 4 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 126.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A3 | Rattus norvegicus (Norway rat) | Ki | 1,450.0000 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 2,430.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | IC50 | 2.8684 | 5 | 11 |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | Ki | 4.1825 | 2 | 4 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 22.3940 | 2 | 5 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 24.9900 | 2 | 4 |
| Solute carrier organic anion transporter family member 2A1 | Rattus norvegicus (Norway rat) | Ki | 47.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | IC50 | 112.0333 | 1 | 3 |
| Solute carrier organic anion transporter family member 2B1 | Homo sapiens (human) | Ki | 105.3000 | 1 | 3 |
| Sphingosine-1-phosphate lyase 1 | Mus musculus (house mouse) | Ki | 0.0150 | 1 | 1 |
| Squalene synthase | Rattus norvegicus (Norway rat) | Ki | 10.0000 | 1 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | IC50 | 200.0000 | 2 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | Homo sapiens (human) | Ki | 0.0815 | 1 | 1 |
| Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | IC50 | 0.8800 | 1 | 1 |
| Steryl-sulfatase | Homo sapiens (human) | IC50 | 0.8000 | 1 | 1 |
| Substance-K receptor | Homo sapiens (human) | IC50 | 6.3860 | 1 | 2 |
| Substance-K receptor | Homo sapiens (human) | Ki | 2.1285 | 1 | 2 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 3.4000 | 1 | 2 |
| Substance-P receptor | Homo sapiens (human) | IC50 | 16.0370 | 1 | 1 |
| Substance-P receptor | Homo sapiens (human) | Ki | 8.7470 | 1 | 1 |
| Suppressor of tumorigenicity 14 protein | Homo sapiens (human) | Ki | 1.1600 | 1 | 1 |
| Synaptic vesicle glycoprotein 2A | Rattus norvegicus (Norway rat) | IC50 | 1,258,930,000,000.0000 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | IC50 | 0.0147 | 3 | 3 |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | IC50 | 0.0177 | 1 | 10 |
| Synaptic vesicular amine transporter | Bos taurus (cattle) | Ki | 0.0010 | 1 | 1 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | Ki | 0.3484 | 3 | 3 |
| Synaptic vesicular amine transporter | Rattus norvegicus (Norway rat) | Ki | 41.2800 | 2 | 2 |
| Thioredoxin reductase | Entamoeba histolytica | Ki | 3.3000 | 1 | 1 |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | IC50 | 100.0000 | 1 | 2 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 17.2115 | 4 | 6 |
| Thymidylate synthase | Escherichia coli K-12 | IC50 | 115.6033 | 2 | 6 |
| Thymidylate synthase | Homo sapiens (human) | IC50 | 115.6033 | 2 | 6 |
| Thymidylate synthase | Mus musculus (house mouse) | IC50 | 2.9833 | 6 | 6 |
| Transcriptional activator protein LasR | Pseudomonas aeruginosa PAO1 | IC50 | 9.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 2 | Homo sapiens (human) | IC50 | 43.3333 | 3 | 3 |
| Transitional endoplasmic reticulum ATPase | Homo sapiens (human) | IC50 | 6.7000 | 2 | 2 |
| Translocator protein | Homo sapiens (human) | IC50 | 89,592.7000 | 1 | 2 |
| Translocator protein | Bos taurus (cattle) | Ki | 0.0009 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | Ki | 0.4060 | 3 | 5 |
| Transporter | Rattus norvegicus (Norway rat) | IC50 | 3.0659 | 14 | 16 |
| Transporter | Rattus norvegicus (Norway rat) | Ki | 1.9951 | 20 | 25 |
| Transthyretin | Homo sapiens (human) | IC50 | 53.5000 | 1 | 1 |
| Trypsin-1 | Homo sapiens (human) | IC50 | 43.3333 | 1 | 3 |
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | Ki | 0.4900 | 1 | 1 |
| Type-1 angiotensin II receptor | Bos taurus (cattle) | IC50 | 0.1800 | 1 | 1 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | IC50 | 0.3136 | 16 | 17 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | Ki | 0.5248 | 8 | 9 |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | Ki | 3.1335 | 2 | 3 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0940 | 3 | 4 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0756 | 4 | 5 |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | Ki | 0.0008 | 1 | 1 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | IC50 | 0.0017 | 2 | 2 |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | IC50 | 0.1217 | 2 | 3 |
| Type-2 angiotensin II receptor | Homo sapiens (human) | Ki | 10.0000 | 2 | 2 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | IC50 | 31.8510 | 1 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | IC50 | 110.0006 | 2 | 2 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 191.6250 | 1 | 8 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | Ki | 23.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 153.7700 | 3 | 10 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | Ki | 52.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | Homo sapiens (human) | Ki | 28.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 191.6250 | 1 | 8 |
| UDP-glucuronosyltransferase 1A7 | Homo sapiens (human) | Ki | 19.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | Homo sapiens (human) | Ki | 11.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 191.6250 | 1 | 8 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 191.6250 | 1 | 8 |
| Ultraspiracle | Nezara viridula (southern green stink bug) | IC50 | 24.0000 | 2 | 2 |
| Ultraspiracle | Chilo suppressalis (striped riceborer) | Ki | 0.0013 | 1 | 1 |
| Ultraspiracle | Chironomus tentans | Ki | 0.0100 | 1 | 1 |
| Ultraspiracle | Nezara viridula (southern green stink bug) | Ki | 22.1781 | 5 | 5 |
| Ultraspiracle | Leptinotarsa decemlineata (Colorado potato beetle) | Ki | 7.5505 | 2 | 2 |
| Ultraspiracle isoform-A | Aedes aegypti (yellow fever mosquito) | Ki | 0.0251 | 1 | 1 |
| Ultraspiracle protein | Lucilia cuprina (Australian sheep blowfly) | Ki | 0.1585 | 1 | 1 |
| Ultraspiracle protein | Bemisia tabaci | Ki | 501.1870 | 1 | 1 |
| Ultraspiracle protein | Myzus persicae (green peach aphid) | Ki | 125.8930 | 1 | 1 |
| unnamed protein product | Aspergillus oryzae RIB40 | IC50 | 49.7510 | 1 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | Homo sapiens (human) | IC50 | 28.8000 | 2 | 2 |
| Urease | Canavalia ensiformis (jack bean) | IC50 | 64.3600 | 1 | 1 |
| Urokinase-type plasminogen activator | Homo sapiens (human) | IC50 | 43.3333 | 1 | 3 |
| USP | Plodia interpunctella (Indianmeal moth) | Ki | 0.0032 | 1 | 1 |
| Vasopressin V1a receptor | Homo sapiens (human) | IC50 | 8.7139 | 2 | 2 |
| Vasopressin V1a receptor | Homo sapiens (human) | Ki | 4.9810 | 1 | 1 |
| Vasopressin V2 receptor | Homo sapiens (human) | IC50 | 9.0402 | 2 | 4 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | Mus musculus (house mouse) | Ki | 0.1201 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 14.1967 | 2 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 8,037.4162 | 13 | 13 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | IC50 | 33,340.5300 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 94.0000 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 94.0000 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 94.0000 | 6 | 6 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 11.5000 | 1 | 2 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 14-alpha sterol demethylase | Aspergillus fumigatus | Kd | 2.0665 | 2 | 2 |
| 20-hydroxy-ecdysone receptor | Choristoneura fumiferana (eastern spruce budworm) | EC50 | 0.2800 | 1 | 1 |
| 20-hydroxy-ecdysone receptor | Spodoptera littoralis (African cotton leafworm) | EC50 | 0.0041 | 1 | 2 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | Kd | 0.0170 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | Kd | 2.5559 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Kd | 0.3621 | 3 | 8 |
| 5-hydroxytryptamine receptor 1B | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | EC50 | 0.6520 | 10 | 10 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | EC50 | 0.7475 | 11 | 11 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Kd | 0.1259 | 1 | 2 |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | EC50 | 0.4773 | 12 | 12 |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | Kd | 0.0501 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | Kd | 0.0501 | 1 | 1 |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | Kd | 0.0501 | 1 | 1 |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | Kd | 0.0501 | 1 | 1 |
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | Kd | 0.0501 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | EC50 | 40.0000 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Acetylcholine receptor subunit alpha | Homo sapiens (human) | EC50 | 25.3333 | 3 | 3 |
| Acetylcholine receptor subunit alpha | Tetronarce californica (Pacific electric ray) | EC50 | 60.0000 | 1 | 1 |
| Acetylcholine receptor subunit beta | Homo sapiens (human) | EC50 | 29.0000 | 3 | 3 |
| Acetylcholine receptor subunit beta | Tetronarce californica (Pacific electric ray) | EC50 | 60.0000 | 1 | 1 |
| Acetylcholine receptor subunit delta | Homo sapiens (human) | EC50 | 33.0000 | 2 | 2 |
| Acetylcholine receptor subunit delta | Tetronarce californica (Pacific electric ray) | EC50 | 110.0000 | 2 | 2 |
| Acetylcholine receptor subunit epsilon | Homo sapiens (human) | EC50 | 65.0000 | 1 | 1 |
| Acetylcholine receptor subunit gamma | Homo sapiens (human) | EC50 | 33.0000 | 2 | 2 |
| Acetylcholine receptor subunit gamma | Tetronarce californica (Pacific electric ray) | EC50 | 60.0000 | 1 | 1 |
| Acetylcholine-binding protein | Lymnaea stagnalis (great pond snail) | Kd | 0.2931 | 3 | 5 |
| Adenosine receptor A1 | Homo sapiens (human) | Kd | 45.0000 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Adenosine receptor A2a | Homo sapiens (human) | Kd | 15.3144 | 2 | 2 |
| Adenosine receptor A3 | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Albumin | Homo sapiens (human) | Kd | 284.3283 | 8 | 12 |
| Albumin | Rattus norvegicus (Norway rat) | Kd | 316.1957 | 1 | 7 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.2638 | 2 | 2 |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.2638 | 2 | 2 |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.2638 | 2 | 2 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | EC50 | 2.5074 | 2 | 2 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 10.2161 | 2 | 2 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 10.2161 | 2 | 2 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 10.2161 | 2 | 2 |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | EC50 | 10.0000 | 1 | 1 |
| Androgen receptor | Homo sapiens (human) | EC50 | 10.0001 | 2 | 2 |
| Angiopoietin-1 receptor | Homo sapiens (human) | Kd | 90.0000 | 1 | 1 |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | EC50 | 3.0800 | 1 | 2 |
| Aryl hydrocarbon receptor | Homo sapiens (human) | EC50 | 1,000.0000 | 1 | 1 |
| bcl-2-like protein 11 isoform 1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 1 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | EC50 | 0.5858 | 2 | 2 |
| Beta-1 adrenergic receptor | Homo sapiens (human) | Kd | 6.9372 | 8 | 24 |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | Kd | 0.0155 | 3 | 5 |
| Beta-1 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0832 | 13 | 16 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0386 | 2 | 2 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | EC50 | 0.8723 | 6 | 6 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.3421 | 8 | 16 |
| Beta-2 adrenergic receptor | Homo sapiens (human) | Kd | 5.9719 | 9 | 31 |
| Beta-2 adrenergic receptor | Bos taurus (cattle) | Kd | 0.5500 | 1 | 2 |
| Beta-3 adrenergic receptor | Homo sapiens (human) | Kd | 7.5747 | 6 | 22 |
| Bromodomain-containing protein 4 | Homo sapiens (human) | Kd | 2.4600 | 1 | 1 |
| calcineurin A1, putative | Candida dubliniensis CD36 | EC50 | 180.0000 | 1 | 1 |
| Calmodulin | Bos taurus (cattle) | Kd | 61.0000 | 1 | 1 |
| Caspase-3 | Homo sapiens (human) | EC50 | 50.0000 | 2 | 2 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | Homo sapiens (human) | EC50 | 30.0000 | 2 | 2 |
| Chain A, BCL-2-RELATED PROTEIN A1 | Homo sapiens (human) | EC50 | 350.0000 | 1 | 1 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | synthetic construct | Kd | 0.4000 | 1 | 1 |
| Chain A, Dihydrofolate Reductase | Staphylococcus aureus | Kd | 0.4300 | 1 | 1 |
| Chain A, Estrogen-related receptor gamma | Homo sapiens (human) | Kd | 0.2241 | 1 | 4 |
| Chain A, Glycogen phosphorylase, liver form | Homo sapiens (human) | Kd | 100.0000 | 1 | 8 |
| Chain A, Odorant binding protein | Anopheles gambiae (African malaria mosquito) | Kd | 31.3000 | 1 | 1 |
| Chain A, Repressor | Stenotrophomonas maltophilia | Kd | 0.6300 | 1 | 1 |
| Chain A, Soluble acetylcholine receptor | Aplysia californica (California sea hare) | Kd | 0.0140 | 1 | 2 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | synthetic construct | Kd | 0.4000 | 1 | 1 |
| Chain B, Odorant binding protein | Anopheles gambiae (African malaria mosquito) | Kd | 31.3000 | 1 | 1 |
| Chain E, Soluble acetylcholine receptor | Aplysia californica (California sea hare) | Kd | 0.0140 | 1 | 2 |
| Chain H, Fab M82G2, Heavy chain | Mus musculus (house mouse) | Kd | 0.1400 | 1 | 2 |
| Chain L, Fab M82G2, Light chain | Mus musculus (house mouse) | Kd | 0.1400 | 1 | 2 |
| Cholecystokinin receptor type A | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | Kd | 189.3000 | 1 | 1 |
| Cytochrome P450 130 | Mycobacterium tuberculosis CDC1551 | Kd | 9.7000 | 1 | 2 |
| Cytochrome P450 130 | Mycobacterium tuberculosis H37Rv | Kd | 10.9000 | 2 | 3 |
| Cytochrome P450 144 | Mycobacterium tuberculosis CDC1551 | Kd | 182.5140 | 1 | 5 |
| Cytochrome P450 1A1 | Rattus norvegicus (Norway rat) | EC50 | 1,000.0000 | 1 | 2 |
| Cytochrome P450 1A1 | Homo sapiens (human) | Kd | 19.1000 | 1 | 1 |
| Cytochrome P450 2A13 | Homo sapiens (human) | Kd | 54.0000 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Kd | 470.0000 | 1 | 1 |
| Cytochrome P450 2B6 | Homo sapiens (human) | EC50 | 145.0000 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Kd | 0.0730 | 1 | 1 |
| Cytochrome P450 3A4 | Homo sapiens (human) | EC50 | 0.3790 | 1 | 1 |
| D(1A) dopamine receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| D(2) dopamine receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | EC50 | 0.6373 | 12 | 12 |
| Delta-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0044 | 1 | 1 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0042 | 2 | 3 |
| Delta-type opioid receptor | Homo sapiens (human) | Kd | 0.0016 | 1 | 1 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | Kd | 0.0111 | 4 | 4 |
| Ecdysone receptor | Bombyx mori (domestic silkworm) | EC50 | 0.0224 | 3 | 5 |
| Ecdysone receptor | Drosophila melanogaster (fruit fly) | EC50 | 7.9092 | 2 | 3 |
| Endothelin-1 receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |
| Estrogen receptor | Homo sapiens (human) | EC50 | 6.5552 | 5 | 5 |
| Estrogen receptor | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 4 |
| Estrogen receptor beta | Homo sapiens (human) | EC50 | 1.7190 | 3 | 3 |
| Estrogen receptor beta | Rattus norvegicus (Norway rat) | EC50 | 150.0000 | 1 | 4 |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | Kd | 4.4100 | 1 | 1 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Kd | 0.1378 | 15 | 15 |
| Free fatty acid receptor 1 | Homo sapiens (human) | EC50 | 812.8310 | 1 | 1 |
| Frizzled-8 | Mus musculus (house mouse) | Kd | 16.8000 | 1 | 1 |
| G-protein coupled receptor 35 | Homo sapiens (human) | EC50 | 8.7000 | 2 | 2 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 0.0740 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Kd | 0.0360 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | EC50 | 0.0235 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | EC50 | 0.1000 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | EC50 | 0.0275 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Kd | 0.0230 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | EC50 | 0.0925 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | EC50 | 0.0703 | 3 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | EC50 | 0.0792 | 5 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Kd | 0.3883 | 2 | 4 |
| Glucocorticoid receptor | Homo sapiens (human) | EC50 | 0.5046 | 42 | 42 |
| Glucocorticoid receptor | Mus musculus (house mouse) | EC50 | 0.0046 | 2 | 2 |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0196 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | EC50 | 60.0000 | 1 | 1 |
| Glutamine synthetase | Homo sapiens (human) | EC50 | 0.0320 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Homo sapiens (human) | EC50 | 3.2000 | 1 | 1 |
| glycogen synthase kinase-3 beta isoform 1 | Homo sapiens (human) | EC50 | 300.0000 | 1 | 2 |
| Glycoprotein IIb | Oryctolagus cuniculus (rabbit) | EC50 | 1.5068 | 1 | 4 |
| GTP-binding protein (rab7) | Canis lupus familiaris (dog) | EC50 | 30.0000 | 1 | 1 |
| GTP-binding protein Rheb | Homo sapiens (human) | Kd | 1,800.0000 | 1 | 1 |
| GTPase KRas | Homo sapiens (human) | Kd | 600.0000 | 1 | 1 |
| heat shock protein 90 | Candida albicans | EC50 | 50.5703 | 3 | 3 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | EC50 | 86.0000 | 1 | 1 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | Kd | 2,050.0000 | 4 | 4 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0026 | 1 | 1 |
| Histamine H1 receptor | Homo sapiens (human) | EC50 | 0.0004 | 1 | 1 |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0724 | 2 | 2 |
| Histamine H1 receptor | Homo sapiens (human) | Kd | 0.0031 | 1 | 1 |
| Histamine H4 receptor | Homo sapiens (human) | Kd | 0.0294 | 4 | 4 |
| Histidine decarboxylase | Rattus norvegicus (Norway rat) | EC50 | 0.0018 | 1 | 2 |
| Hsf1 protein | Mus musculus (house mouse) | EC50 | 195.0000 | 1 | 1 |
| Integrin beta | Oryctolagus cuniculus (rabbit) | EC50 | 1.5068 | 1 | 4 |
| Kappa-type opioid receptor | Homo sapiens (human) | EC50 | 0.7684 | 10 | 10 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.2004 | 2 | 2 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0018 | 1 | 2 |
| Lanosterol 14-alpha demethylase | Candida albicans SC5314 | Kd | 0.0450 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Homo sapiens (human) | Kd | 76.6667 | 3 | 3 |
| Lanosterol 14-alpha demethylase | Mycobacterium tuberculosis CDC1551 | Kd | 30.0000 | 1 | 1 |
| Lanosterol 14-alpha demethylase | Mycobacterium tuberculosis H37Rv | Kd | 25.1000 | 3 | 4 |
| LAP4 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 0.9120 | 1 | 1 |
| Leukotriene B4 receptor 2 | Homo sapiens (human) | EC50 | 10.4700 | 1 | 3 |
| Major prion protein | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Mas-related G-protein coupled receptor member X2 | Homo sapiens (human) | EC50 | 7.4000 | 2 | 4 |
| MEP2 | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 1.2260 | 1 | 1 |
| Mineralocorticoid receptor | Homo sapiens (human) | EC50 | 0.0010 | 2 | 2 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | EC50 | 0.0019 | 1 | 1 |
| Mu-type opioid receptor | Homo sapiens (human) | EC50 | 0.4577 | 30 | 32 |
| Mu-type opioid receptor | Mus musculus (house mouse) | EC50 | 0.0376 | 3 | 4 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0979 | 7 | 8 |
| Mu-type opioid receptor | Homo sapiens (human) | Kd | 0.0001 | 1 | 1 |
| Multidrug resistance protein MdtK | Escherichia coli K-12 | Kd | 94.6500 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | EC50 | 7.5059 | 2 | 2 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | EC50 | 103.0143 | 2 | 7 |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | EC50 | 7.5059 | 2 | 2 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | EC50 | 103.0143 | 2 | 7 |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | EC50 | 7.5059 | 2 | 2 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | EC50 | 103.0143 | 2 | 7 |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | EC50 | 10.0000 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | EC50 | 103.0143 | 2 | 7 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | EC50 | 103.0143 | 2 | 7 |
| Mycocyclosin synthase | Mycobacterium tuberculosis H37Rv | Kd | 3.0365 | 2 | 2 |
| Neuromedin-K receptor | Cavia porcellus (domestic guinea pig) | Kd | 0.0024 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-10 | Rattus norvegicus (Norway rat) | EC50 | 40.6667 | 2 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | EC50 | 35.5000 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | Homo sapiens (human) | EC50 | 21.3260 | 14 | 15 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | EC50 | 30.2517 | 7 | 8 |
| Neuronal acetylcholine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | EC50 | 3.1424 | 20 | 24 |
| Neuronal acetylcholine receptor subunit alpha-4 | Mus musculus (house mouse) | EC50 | 0.7222 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | EC50 | 10.7398 | 12 | 12 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-5 | Homo sapiens (human) | EC50 | 30.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | EC50 | 35.5000 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-6 | Homo sapiens (human) | EC50 | 0.1270 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | EC50 | 35.5000 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | EC50 | 55.2158 | 6 | 6 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | EC50 | 3,948.0836 | 10 | 11 |
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | Kd | 0.0011 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit alpha-9 | Rattus norvegicus (Norway rat) | EC50 | 35.5000 | 2 | 2 |
| Neuronal acetylcholine receptor subunit alpha-9 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | EC50 | 9.3127 | 23 | 27 |
| Neuronal acetylcholine receptor subunit beta-2 | Mus musculus (house mouse) | EC50 | 0.7222 | 1 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | EC50 | 10.7398 | 12 | 12 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit beta-3 | Homo sapiens (human) | EC50 | 10.5635 | 2 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | Rattus norvegicus (Norway rat) | EC50 | 35.5000 | 2 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Neuronal acetylcholine receptor subunit beta-4 | Homo sapiens (human) | EC50 | 13.6576 | 14 | 15 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | EC50 | 30.2517 | 7 | 8 |
| Neuronal acetylcholine receptor subunit beta-4 | Rattus norvegicus (Norway rat) | Kd | 14,352.0000 | 3 | 3 |
| Nociceptin receptor | Rattus norvegicus (Norway rat) | EC50 | 0.0034 | 1 | 1 |
| NPYLR7B | Aedes aegypti (yellow fever mosquito) | EC50 | 20.0000 | 1 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | EC50 | 8.3000 | 2 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | Rattus norvegicus (Norway rat) | EC50 | 4.0000 | 1 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | Homo sapiens (human) | EC50 | 33.6667 | 3 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | Homo sapiens (human) | Kd | 0.5000 | 1 | 1 |
| ORF73 | Human gammaherpesvirus 8 | EC50 | 75.0000 | 1 | 2 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | EC50 | 45.8000 | 1 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | Homo sapiens (human) | Kd | 85.0000 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | EC50 | 33.5600 | 24 | 30 |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | EC50 | 52.0000 | 3 | 4 |
| Peroxisome proliferator-activated receptor alpha | Rattus norvegicus (Norway rat) | EC50 | 29.5000 | 2 | 2 |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | EC50 | 41.8800 | 11 | 11 |
| Peroxisome proliferator-activated receptor delta | Mus musculus (house mouse) | EC50 | 76.6667 | 3 | 3 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | EC50 | 27.5769 | 54 | 68 |
| Peroxisome proliferator-activated receptor gamma | Mus musculus (house mouse) | EC50 | 60.8833 | 4 | 6 |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | Kd | 55.4355 | 2 | 2 |
| Platelet glycoprotein VI | Homo sapiens (human) | Kd | 100.0000 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | EC50 | 377.0000 | 1 | 1 |
| Procathepsin L | Homo sapiens (human) | EC50 | 3.0800 | 1 | 2 |
| Progesterone receptor | Homo sapiens (human) | EC50 | 20.0000 | 1 | 1 |
| Prostaglandin D2 receptor 2 | Homo sapiens (human) | EC50 | 0.3890 | 1 | 2 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Kd | 1.0200 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | EC50 | 0.1500 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Kd | 0.1927 | 2 | 3 |
| Protein S100-B | Homo sapiens (human) | Kd | 1.0000 | 1 | 1 |
| Protein S100-B | Rattus norvegicus (Norway rat) | Kd | 47.0000 | 2 | 2 |
| Protein ultraspiracle | Drosophila melanogaster (fruit fly) | EC50 | 7.9092 | 2 | 3 |
| Proteinase-activated receptor 1 | Homo sapiens (human) | EC50 | 0.0037 | 1 | 2 |
| Rac1 protein | Homo sapiens (human) | EC50 | 30.0000 | 2 | 2 |
| ras protein, partial | Homo sapiens (human) | EC50 | 15.1885 | 2 | 2 |
| Ras-related protein Rab-2A | Canis lupus familiaris (dog) | EC50 | 30.0000 | 1 | 1 |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | EC50 | 3.0800 | 1 | 2 |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | EC50 | 3.0800 | 1 | 2 |
| Replicase polyprotein 1ab | Human coronavirus 229E | EC50 | 3.0800 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | EC50 | 3.0800 | 1 | 2 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | EC50 | 3.0800 | 1 | 2 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | Homo sapiens (human) | Kd | 1.2500 | 1 | 1 |
| RPL19A | Saccharomyces cerevisiae (brewer's yeast) | EC50 | 11.8900 | 1 | 1 |
| short transient receptor potential channel 6 isoform 1 | Mus musculus (house mouse) | EC50 | 15.8500 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | EC50 | 86.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | EC50 | 30.0000 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 15.1885 | 2 | 2 |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | Kd | 0.1600 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | EC50 | 0.0491 | 1 | 1 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Kd | 5.1900 | 1 | 2 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | EC50 | 0.9200 | 1 | 1 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Kd | 0.5310 | 1 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | EC50 | 0.7090 | 2 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Kd | 0.0089 | 1 | 2 |
| Spike glycoprotein | Betacoronavirus England 1 | EC50 | 3.0800 | 1 | 2 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | EC50 | 3.0800 | 1 | 2 |
| Steroid C26-monooxygenase | Mycobacterium tuberculosis CDC1551 | Kd | 153.7117 | 2 | 12 |
| Sterol 14-alpha demethylase | Aspergillus fumigatus Af293 | Kd | 8.3600 | 1 | 2 |
| Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | Kd | 0.2575 | 3 | 4 |
| streptokinase A precursor | Streptococcus pyogenes M1 GAS | EC50 | 51.9962 | 2 | 6 |
| Synaptic vesicular amine transporter | Homo sapiens (human) | Kd | 0.0080 | 1 | 1 |
| Taste receptor type 2 member 1 | Homo sapiens (human) | EC50 | 36,300.0000 | 1 | 1 |
| Taste receptor type 2 member 31 | Homo sapiens (human) | EC50 | 8,670.0000 | 2 | 4 |
| Taste receptor type 2 member 46 | Homo sapiens (human) | EC50 | 31.0000 | 1 | 1 |
| Trace amine-associated receptor 1 | Homo sapiens (human) | EC50 | 1.4000 | 2 | 2 |
| Trace amine-associated receptor 1 | Macaca mulatta (Rhesus monkey) | EC50 | 5.3000 | 1 | 1 |
| Trace amine-associated receptor 1 | Mus musculus (house mouse) | EC50 | 0.6217 | 5 | 5 |
| Trace amine-associated receptor 1 | Rattus norvegicus (Norway rat) | EC50 | 0.8173 | 4 | 4 |
| Trace amine-associated receptor 5 | Mus musculus (house mouse) | EC50 | 10.0000 | 1 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | Homo sapiens (human) | EC50 | 50,836.6324 | 3 | 9 |
| Transient receptor potential cation channel subfamily A member 1 | Mus musculus (house mouse) | EC50 | 10.0000 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | EC50 | 0.0156 | 1 | 1 |
| Translocator protein | Rattus norvegicus (Norway rat) | Kd | 0.2130 | 1 | 1 |
| Transmembrane protease serine 2 | Homo sapiens (human) | EC50 | 3.0800 | 1 | 2 |
| Transporter | Rattus norvegicus (Norway rat) | EC50 | 51.0000 | 1 | 1 |
| Transthyretin | Homo sapiens (human) | Kd | 48.3533 | 3 | 3 |
| Type-1 angiotensin II receptor | Homo sapiens (human) | EC50 | 8.3373 | 3 | 3 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | EC50 | 10.0000 | 1 | 1 |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | Kd | 0.0032 | 1 | 1 |
| Vasopressin V1a receptor | Homo sapiens (human) | EC50 | 5.0119 | 1 | 1 |